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 ABSTRACT  
The T cell compartment consists of two major subsets with diverse assignments. 
CD4+ T cells express CD40L upon activation, a central co-stimulatory receptor to 
induce B cell mediated humoral immunity, activate APCs and prime efficient 
effector CD8+ T cell development (“helper function”). In contrast, cytotoxic CD8+ 
T cells are predetermined to kill infected or malignant cells directly. However, a 
fraction of CD8+ T cells expressing CD40L upon activation was identified. So far, 
it is not understood in CD8+ T cells a) how CD40L expression is regulated, b) 
when and how the ability of CD40L expression is implemented and c) what are 
the implications for the immune system. 
In this thesis, we found that CD40L expression is regulated by DNA-methylation 
of regulatory regions of the CD40LG locus in CD4+ as well as CD8+ T cells. The 
de-methylation of central elements is implemented in the thymus and increases 
with T cell maturation reflected by enhanced stability of CD40L expression. 
Elevated CD5 and NUR77 expression of CD40L+ CD8+ SP thymocytes suggests 
that high affine detection of self-peptides during positive selection in the thymus 
implements CD40L expression ability and predetermines the fate of the CD40L 
imprinted CD8+ T cells. CD40L+ naïve CD8+ T cells differ in their TCR repertoire 
from their CD40L- counterparts and preferentially mature into memory cell 
subsets with cytokine and chemokine receptor profiles of Tc2, Tc17 and Tc22 
cells. With their non-cytotoxic phenotype and gene expression signatures, the 
CD40L+ memory CD8+ T cell subsets Tc2, Tc17 and Tc22 widely resemble helper 
CD4+ T cells and can be distinguished from classical cytotoxic Tc1 and Tc17+1 
cells by their IL-6R and absent SLAMF7 expression and their skin migratory 
phenotype. 
Altogether, we demonstrate that from the earliest developmental stages in 
thymus onwards naive CD8+ T cells are not homogenous and the abilites to 
provide “CD40L based help” or “cytotoxicity mediated killing” are independent of 
the CD4+ or CD8+ T cell status. Cells with helper-type CD8+ T cell cytokine and 
gene-expression signatures were found at barrier sites (skin, lung) by us and 
others where they contribute to multiple autoinflammatory diseases. Therefore, 
this work insinuates the need to revisite CD8+ T cell capablities and function in 
immune responses.  
  
 ZUSAMMENFASSUNG 
T Zellen können in zwei Hauptpopulationen mit unterschiedlichen Aufgaben 
unterschieden werden. CD4+ T Zellen exprimieren im Zuge ihrer Aktivierung 
CD40L, welches ein zentraler kostimulatorischer Rezeptor zur Induktion von B-
Zell basierter humoraler Immunität, APC Aktivierung und einer effizienten 
Effektor CD8+ T Zell Entwicklung ist („Helfer-Funktion“). Im Gegensatz dazu sind 
die zytotoxischen CD8+ T Zellen dazu vorbestimmt, infizierte oder maligne Zellen 
direkt abzutöten. Jedoch wurde eine Fraktion von CD8+ T Zellen identifiziert, die 
nach Aktivierung CD40L exprimiert. Bisher ist nicht verstanden, wie in solchen 
CD8+ T Zellen a) die CD40L Expression reguliert ist, b) wann und wie die 
Fähigkeit CD40L zu exprimieren implementiert wird und c) was die Folgen für das 
Immunsystem sind.  
In dieser Arbeit konnten wir zeigen, dass sowohl in CD4+ als auch in CD8+ T 
Zellen die CD40L Expression durch DNA-Methylierung regulatorischer Regionen 
des CD40LG Lokus reguliert wird. Die Demethylierung zentraler Elemente wird 
im Thymus implementiert, manifestiert sich mit der T-Zell Reifung und geht mit 
einer zunehmenden Stabilität der CD40L Expression einher. Erhöhte Expression 
von CD5 und NUR77 in CD40L+ CD8+ SP Thymozyten weisen auf eine positive 
Selektion mit hoher Affinität gegen Selbst-peptide während der Reifung im 
Thymus hin, welche das weitere Schicksal der CD40L exprimierenden CD8+ T 
Zellen beeinflusst. Naive CD40L+ CD8+ T Zellen besitzen ein anderes TCR 
Repertoire als CD40L- CD8+ T Zellen und reifen im Zuge ihrer Aktivierung 
bevorzugt zu Gedächtniszellen mit Zytokin- und Chemokinrezeptorprofilen von 
Tc2, Tc17 und Tc22 Zellen heran. Mit ihrem nicht-zytotoxischen Phänotyp und 
ihrer Genexpressionsignatur ähneln diese Zellen stark Helfer-CD4+ T Zellen und 
können von den klassisch zytotoxischen Tc1 und Tc17+1 Zellen durch ihre IL-6R 
und fehlende SLAMF7 Expression sowie der Expression von Markern die auf 
eine Fähigkeit in die Haut zu wandern schließen lassen, unterschieden werden.  
Zusammenfassend zeigen wir hier, dass naive CD8+ T Zellen von den frühsten 
Entwicklungsstadien im Thymus an nicht homogen sind und die Fähigkeiten über 
CD40L Expression eine Helferfunktion auszuüben beziehungsweise über die 
Sekretion zytolytischer Moleküle Zielzellen abzutöten unabhängig vom CD4+ or 
CD8+ T-Zell Status sind. Zellen mit Zytokin- und Genexpressionsignaturen, die 
mit denen der CD8+ Helfer-T Zellen übereinstimmen, wurden von uns und 
anderen in Geweben (Haut, Lunge) identifiziert und tragen zu den 
verschiedensten autoinflammatorischen Erkrankungen bei. Diese Arbeit 
insinuiert daher die Notwendigkeit einer grundlegenen Neubewertung der CD8+ 
T Zell Fähigkeiten und Funktionen in Immunantworten. 
 ABBREVIATIONS  
APC  Antigen Presenting Cell 
BrefA  BrefeldinA  
BSA  Bovine Serum Albumin 
CaN  Calcineurin 
CCR  C-C motive Chemokine Receptor 
CM  Central Memory  
CsA  Cyclosporine A  
CXCR  C-X-C motive Chemokine Receptor 
DAPI  4′,6-Diamidin-2-Phenylindol 
DC  Dendritic Cell 
DN  Double Negative (CD4-CD8-) T cell 
DNA  Deoxyribonucleic Acid 
DNMT DNA Methyltransferase 
DP  Double Positive (CD4+CD8+) T cell 
E  Effector  
EM  Effector Memory  
ER  Endoplasmatic Reticulum 
FACS  Fluorescence Activated Cell Sorting 
IFN  Interferon 
IL  Interleukin 
Iono  Ionomycin 
KO  Knockout  
Kb  Kilobase 
MACS Magnetic Cell Separation 
MFI  Mean Fluorescence Intensity 
MHC  Major Histocompatibility Complex 
MФ  Macrophage 
N  Naïve  
NFAT  Nuclear Factor of Activated T cells 
NF-κB  Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells 
O/N  Over Night 
PBMC Peripheral Blood Mononuclear Cells  
PBS  Phosphate Buffered Saline 
PI  Propidium Iodide 
PMA  Phorbol 12-myristat-13-acetate 
PRR  Pattern Recognition Receptors 
qPCR  Quantitative Real Time PCR 
RNA  Ribonucleic Acid 
RT  Room Temperature 
SEB  Staphylococcus Aureus Enterotoxin B 
Seq  Sequencing 
SP  Single Positive (CD4+CD8- or CD4-CD8+) T cell 
TCR  T Cell Receptor 
Tc  T Cytotoxic 
TF  Transcripton Factor 
TFH  T Follicular Helper Cell 
Th  T Helper 
TMNP  Memory T Cells with Naïve Phenotype 
TREC  T Cell Receptor Excision Circles 
Treg  T Regulatory Cell 
TRM  Tissue Resident Memory T Cell 
TSCM  T Memory Stem Cell  
TSST1 Toxic Shock Syndrome Toxin 1 
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1.  INTRODUCTION 
1.1  The immune system 
The evolution not only led to the development of highly evolved multicellular 
organisms but also gave rise to organisms with a parasitic and/or symbiotic 
lifestyle. The existence of these potential harmful threats forced the development 
of protective mechanisms. Prokaryotes possess a rudimentary defense system 
based on DNA cleaving that recently became well known as genome editing tool 
CRISPR (Marraffini, 2015). Among eukaryotes, invertebrates express germline-
encoded pattern recognition receptors (PRRs) of the innate immune system that 
detect conserved structures among pathogens and provoke according immune 
responses whereas an adaptive immunity developed later with the rise of the 
vertebrates (Kawai and Akira, 2011). The adaptive immune system is 
characterized by a sheer unlimited ability of pathogen sensing provided by a 
flexible arrangement of antigen recognizing receptors of the two pillars of 
adaptive immunity: B cells and T cells. B cells mediate humoral immunity that 
protects the liquid systems by antibody secretion whereas T cells are capable to 
exert cell-mediated immunity (Iwasaki and Medzhitov, 2015). 
 
1.2  T cells 
1.2.1  The T cell receptor  
Some lymphoid progenitors mature in the bone marrow to B cells whereas others 
migrate into the thymic cortex where they develop into T cells. T cells are 
characterized by a highly diverse T cell receptor (TCR) that is responsible for the 
detection of potential threats. In most T cells, the TCR consist of α- and β-chain 
that are formed by random joining of multiple regions of exonic DNA. The region 
for the first rearranged β-chain consists of 42 Vβ (variable), 2 Dβ (diversity), 13 
Jβ (joining) and 2 Cβ (constant) segments. RAG enzymes splice one segment of 
each region together to form a functional V-D-J variable region that is linked to a 
constant segment to form a complete β-chain. Successful arrangement leads to 
a proliferation burst and the recombination of the α-chain locus consisting of 43 
Vα and 58 Jα segments of which one each is spliced together with one Cα 
I N T R O D U C T I O N  
 
2 
segment into a V-J-C α-chain resulting in several cells presenting a complete α/β 
TCR at the cell surface with the same β- but various α-chains (Kreslavsky et al., 
2012; Laydon et al., 2015). Off note, a small fraction of lymphoid progenitors in 
the thymus instead rearrange γ- and δ-locus and become γ/δ T cells that do not 
express CD4 or CD8 coreceptor and possess distinct properties (Vantourout and 
Hayday, 2013).  
The variable regions of the α- and the β- chain consisting of the variously 
recombined V, D and J segments define the antigen detection properties of the 
TCR. The TCR detects antigens presented on major histocompatibility complex 
(MHC) by an antigen presenting cell (APC). This interaction mostly occurs at 
specific regions called complementary-determining regions (CDRs). While CDR1 
and CDR2 are involved in MHC binding, CDR3 is critical for the antigen 
recognition (Kranz, 2005) (Figure 1). This variation leads to 3x1011 possible TCR 
recombinations of which around 2.5x107 can be found among naïve T cells in 
human. As each TCR is capable of detecting up to 106 peptide:MHC complexes, 
T cells can provide immunity against nearly every threat that is encountered 
during lifetime (Wooldridge et al., 2012). 
  
Figure 1: Antigen/MHC complex detection by the TCR. 
Antigen presenting cells (APC) present the antigen to the TCR on the T cell which consists 
of an α- and a β- chain. Both chains have a constant (C) region and a variable (V) region that 
interacts with the antigen in the complementary-determining region 3 (CDR3) and with the 
MHC in the CDR1 and CDR2 regions. 
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1.2.2  T cell development 
Maturation of T cells in the thymus progresses over several consecutive steps 
from CD4-CD8- double negative stage 1 (DN1) via DN2 to DN3 stage while they 
rearrange their β-chain of their TCR and present it with a non-rearranged α-chain 
as preliminary T cell receptor. Successful presentation leads to a rearrangement 
of the α-chain in DN4 stage and the presentation of a fully rearranged TCR 
together with CD4 and CD8 co-receptors in double positive (DP) stage (Germain, 
2002) (Figure 2).  
 
Figure 2: Stages of T cell development. Adapted from (Weerkamp et al., 2006). 
Stem cell like cells migrate from the bone marrow via blood into the thymus where they enter 
the CD4-CD8- double negative (DN) stage 1. TCR recombination events during the 
maturation steps DN2, DN3 and DN4 lead to co-expression of CD4 and CD8 in the double 
positive (DP) stage. Successful selection is accompanied by upregulation of CD3 and a 
CD4+CD8- or CD4-CD8+ single positive (SP) lineage commitment. Mature cells egress from 
thymus and circulate as naïve cells through blood and lymph until they encounter their 
cognate antigen. 
 
The responsiveness of the newly arranged TCR is tested by a highly specialized 
variant of APCs, thymic epithelial cells (TECs) that present autoantigens on major 
histocompatibility complex (MHC) type I or type II. Too weak or absent MHC 
detection by the TCR leads to cell death by neglect (positive selection) in the 
cortex whereas too strong self affine clones are eliminated in the medulla by 
negative selection to avoid autoantigen targeting T cells in the periphery (Klein et 
al., 2014; Takaba and Takayanagi, 2017) (Figure 3). 
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Figure 3: TCR affinity during T cell selection decides T cell fate. Adapted from (Klein et 
al., 2014) 
Lack of TCR stimuli leads to death by neglect. Weak affinity TCR signaling induces positive 
selection and give rise to naïve T cells. Increasing affinity of the TCR induces the 
differentiation of Tregs from CD4+ T cells or elimination by negative selection. 
 
1.2.3  The thymic cortex: positive selection and CD4+ vs. CD8+ T cell fate 
decision 
The cTECs of the thymic cortex mediate positive selection by presenting a unique 
MHC ligandome. This ligandome consists of “private peptides” provided by the 
thymoproteasome subunit β5t, which possesses a unique substrate preference 
responsible for MHCI specific peptide processing and loading (Murata et al., 
2007). The cTECs furthermore exclusively utilize cathepsin L and TSSP1 
combined with strong autophagy for the processing of MHCII specific peptides. It 
is speculated that these highly specialized mechanisms for antigen presentation 
are evolved in order to increase the overall TCR repertoire by enhancing the 
numbers of clones with a low affinity passing the positive selection (Gommeaux 
et al., 2009; Hsieh et al., 2002; Xing et al., 2013). Furthermore, it creates a peptide 
pool different from constitutive proteasomes acting during negative selection in 
order to avoid elimination of all positively selected T cells (peptide-switch model) 
(Kincaid et al., 2016).  
CD4+CD8+ DP T cells wander through the cortex and scan the cTECS for 
their TCR specific peptide presented either on MHC type I or MHC type II. Upon 
binding to peptide-MHC complexes, independent of the MHC class, the CD8 co-
receptor is downregulated (Brugnera et al., 2000). Since the CD8 co-receptor 
specifically binds to MHCI whereas CD4 co-receptor attaches to MHCII, 
downregulation of CD8 destabilizes MHCI:TCR interactions compared to 
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MHCII:TCR complexes. Therefore, detection of an MHCII:peptide complex leads 
to a comparatively long and strong TCR signaling activating a CD4 lineage 
manifesting transcription factor network (Liu and Bosselut, 2004). In contrast, 
MHCI specific cells loose contact to the cTEC after short MHC signaling due to 
the downregulated CD8 co-receptor and become susceptible to intrathymic IL-7 
signaling (Brugnera et al., 2000; Park et al., 2010). This combination activates 
CD8-associated transcription factors that not only promote the development of 
CD8+ T cells but also repress CD4+ T cell related genes and therefore determine 
a CD8+ T cell fate (Cruz-Guilloty et al., 2009; Setoguchi et al., 2008). 
The avidity of the TCR for the MHC presented peptide during positive 
selection influences the functional attributes of the T cell in periphery in terms of 
responsiveness, survival and development (Persaud et al., 2014). Avidity 
composes of the sum of multiple interactions with specific affinities that result 
from the binding strength of the TCR to the MHC presented peptide. High avidity 
goes along with prolonged TCR signaling and an increase of the TCR signaling 
repressors CD5 and NUR77 that are important for the fine tuning of TCR signaling 
response (Azzam et al., 1998; Moran et al., 2011) (Figure 4).   
 
Figure 4: TCR avidity during positive selection decides CD8+ versus CD4+ T cell fate 
and is reflected by CD5 and NUR77 expression levels.  Adapted from (Hogquist and 
Jameson, 2014). 
 
1.2.4  The T cell linage transcription factors: ThPOK and Runx3 
The CD4 versus CD8 lineage decision is mainly regulated by the transcription 
factors ThPOK and Runx3 accompanied by concerted changes in the epigenetic 
landscape. Long and strong TCR signaling activates the CD4 lineage 
transcription factor ThPOK, which represses CD8 lineage associated genes, 
I N T R O D U C T I O N  
 
6 
opposes the Runx3 dependent activation of the CD4 silencer and imprints CD4 
lineage fate by TET mediated DNA demethylation of the CD4 locus (Egawa and 
Littman, 2008; Muroi et al., 2008; Wang et al., 2008). Efficient CD4 imprinting 
further requires concerted action of several other transcription factors, which are 
also activated by strong TCR stimuli. A potent activation of ThPOK is dependent 
on GATA3 induction by c-MYB (Maurice et al., 2007). GATA3 not only promote 
ThPOK expression itself but also represses CD8 lineage decision by inhibiting 
Runx3 expression (Wang et al., 2008; Xiong et al., 2013). Besides, the 
transcription factors TCF-1 and LEF-1 are indispensable to reach sufficient 
ThPOK levels for CD4+ T cell differentiation as well as TOX for complete CD4+ T 
cell maturation (Aliahmad et al., 2011; Steinke et al., 2014) (Figure 5). 
In contrast, short TCR signaling leads to Runx3 activation by IL-7 and IL-
15 signaling in a STAT5 dependent manner and results in the re-expression of 
the CD8 co-receptor (Park et al., 2010) (Figure 5). Besides IL-6, IFN-, TGFβ and 
TSLP can induce Runx3 and drive CD8+ lineage development (Etzensperger et 
al., 2017). The CD8+ T cell fate is stabilized by the ThPOK silencer, which 
mediates a strong epigenetic silencing of the ThPOK locus in the absence of 
strong TCR stimuli as well as by histone deacetylase mediated silencing of the 
CD4 locus (Boucheron et al., 2014; Tanaka et al., 2013).  
 
Figure 5: Lineage transcription factors ThPOK and Runx3 regulate CD4+ versus CD8+ 
T cell fate. Adapted from (Mookerjee-Basu and Kappes, 2014). 
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1.2.5  The thymic medulla: negative selection and tolerance induction 
After positive selection and CD4 versus CD8 fate decision, induced CCR7 
expression mediates the migration of developing T cells into the thymic medulla 
that consists of a network of mTECs, dendritic cells (DCs) and B cells (Kurobe et 
al., 2006). Medullary TECs present high levels of self-peptides controlled by the 
AIRE gene (Derbinski et al., 2001; Heino et al., 1999). AIRE orchestrates the 
activation of silent gene loci and initiates promiscuous gene expression 
(Anderson et al., 2002; Meredith et al., 2015). T cells wander through the network 
and scan the APC for cognate antigens. Persistent TCR signaling in response to 
autoantigens leads to the induction of apoptosis and therefore elimination of the 
T cells from the repertoire by negative selection (Strasser et al., 2007). From 
CD4+ T cells, a stochastic overlap between survival and elimination is known (see 
Figure 3). A strong but transient interaction of high self-affine CD4+ T cells with 
medullary APC can result into the implementation of a natural regulatory T cell 
(nTreg) fate by FoxP3 induction - a process called agonistic selection as it bases 
on self-antigen MHC complex detection (Hsieh et al., 2012; Li and Rudensky, 
2016; Takaba and Takayanagi, 2017). Finally, the cells that succeeded to pass 
selection undergo several rounds of proliferation while they upregulate S1P1 
receptor and egress from the thymus into the periphery as naïve T cells (Carlson 
et al., 2006; Pénit and Vasseur, 1997).  
 
1.2.6  T cells in immune response 
In the periphery, mature T cells migrate through blood and secondary lymphatic 
organs where they scan APCs for their cognate antigen (Masopust and Schenkel, 
2013). The specificity of T cells for a particular antigen lies at around 1 in 100.000. 
For proper immune defense, a clonal burst of short-lived effector cells occurs 
following antigen recognition, increasing the cell numbers up to 107 progenies 
while migrating to the site of infection (Blattman et al., 2002). After the infection 
is cleared, 90-95% of the effector cells die in the contraction phase leaving behind 
a small memory fraction characterized by a strong, cytokine independent 
response upon secondary pathogen exposure (Williams and Bevan, 2007) 
(Figure 6).  
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Figure 6: Kinetic of CD8+ T cell response. Adapted from (Kaech and Cui, 2012). 
 
This memory compartment – the hallmark of adaptive immunity – can be roughly 
subdivided according to their steady state migration potential and tissue 
surveillance capacity into CD45RA-CD45RO+CCR7+ central memory (CM) and 
CCR7- effector memory (EM) cells (Sallusto et al., 1999). CCR7 enables CM to 
migrate through areas of secondary lymphoid organs. They produce high levels 
of IL-2 and efficiently differentiate into effector cells after re-activation. In contrast, 
EM home into inflamed tissue and can provide rapid effector function by secretion 
of cytokines and cytolytic molecules. Some effector cells instead re-express 
CD45RA and become terminally differentiated effectors (EMRA) (Sallusto et al., 
2004). Upon activation and inflammation T cells also can migrate into tissue 
where they upregulate CD103 and/or CD69 and become tissue resident memory 
(TRM) cells (Jameson and Masopust, 2018).  
There are different models how the differentiation into short-lived effector 
and different memory populations is regulated (Figure 7). The separate-
precursor model suggests a fate imprinting in the thymus whereas the 
decreasing-potential model implies an effect of repeated stimuli on 
differentiation. According to the signal strength model, the strength of TCR 
stimulus combined with co-stimulus and cytokine signal decide the fate. A weak 
stimulus gives rise to CM followed EM and effector cells. Finally, the asymmetric 
cell fate model implies that the daughter cell, which is connected to the APC by 
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the immunological synapse, receives a stronger stimulation leading to effector 
cell differentiation, while the other cell experiences a weaker stimulus and 
differentiates into a memory cell (Kaech and Cui, 2012). Extensive analyses on 
single cell levels in murine models revealed that memory formation is only 
predictable on population but not on single cell level (probably due to local 
differences in antigen presentation or cytokines) with an overall tendency to 
progressively differentiate from N to CM to EM to EMRA (Aalderen et al., 2017; 
Buchholz et al., 2013; Gerlach et al., 2013). Global TCR sequencing of T cells 
derived from diverse human organs suggest that effector and EMRA cells 
develop separatedly from a common precursor that can give rise to CM, EM and 
TRM as postulated in the separate precursor model (D. Farber, unpublished). 
 
Figure 7: Different models of T cell differentiation. Adapted from (Kaech and Cui, 2012).  
 
1.2.7  CD4+ T cells 
CD4+ T cells are specialized to detect antigens bound to MHCII receptors that 
are expressed on professional APCs such as dendritic cells (DC), macrophages 
(MФ), B cells as well as on endothelial and epithelial cells. The antigen presenting 
cells sample potential threats from extracellular fluids, internalize them and load 
them onto MHCII in the endolysosomal compartment before transporting to the 
surface (Blum et al., 2013; Neefjes et al., 2011; Vyas et al., 2008). Danger signals 
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by pattern recognition receptors that detect conserved pathogen structures 
activate the APCs and they wander into draining lymph nodes while differentiating 
into mature APCs with increasing expression of MHCII and costimulatory 
molecules such as CD80 and CD86 (Tan and O’Neill, 2005). Naïve CD4+ T cells 
become activated upon recognition of the subsequent antigen presented on the 
APC leading to the differentiation into highly specialized subsets dependent on 
the local cytokine milieu (Sallusto, 2016). The first described subsets Th1 and 
Th2 are induced by the cytokines IL-12/ IFN- and IL-4 respectively that activate 
the lineage specific transcription factors (TF) T-bet (Th1) and GATA3 (Th2) 
(Constant and Bottomly, 1997). While IFN- secreting Th1 are important for 
inflammatory responses, IL-4, IL-5 and IL-13 secreting Th2 can activate mast 
cells and eosinophils. Both promote humoral immune response by activating B 
cells in a CD40L dependent manner and inducing hyperproliferation as well as 
class-switching into diverse immunoglobulins (Smith et al., 2000). Since, several 
further CD4+ T cell subsets were identified as summarized in Table 1.  
Subset 
Transcription-
factors 
Cytokines 
Surface-
markers 
Function  
Th1 T-bet IFN- 
CCR6-     
CXCR3+   
CCR4- 
Intracellular bacteria, viruses, 
autoimmunity 
Th2 GATA3 
IL-4             
IL-5                
IL-13 
CCR6-    
CXCR3-    
CCR4+ 
B cell help, extracellular 
parasites, allergy 
Th17 RORt IL-17 
CCR6+   
CXCR3-    
CCR4+    
CCR10- 
Bacteria, fungi, autoimmunity 
Th22 AHR IL-22 
CCR6+   
CXCR3-   
CCR4+   
CCR10+ 
Skin inflammation 
Th17+1 
T-bet              
RORt 
IFN-            
IL-17 
CCR6+  
CXCR3+   
CCR4- 
Autoimmunity 
Th9 PU.1              IRF4 IL-9 
CCR6+   
CXCR3+  
CCR3+ 
Allergy 
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Treg FoxP3 
IL-10       
TGF-β 
CD25+ Immune regulation 
TFH Bcl6 diverse 
CXCR5+  
CCR7+ 
Germinal center help 
TRM ? diverse 
CD103+   
CD62L-     
CCR7-      
CD69+ 
Barrier defense 
Cytotoxic 
CD4 
Eomes?                
T-bet? 
IFN- 
CD27-        
CD28-       
CD57+  
CRTAM+ 
Intracellular bacteria, viruses 
Table 1: The diversity of CD4+ T cell subsets. Adapted and modified from (Sallusto, 2016). 
 
Within memory cells, subsets with specific cytokine secretion profiles can be 
distinguished by the expression of specialized homing receptors that regulate the 
migration to tissue and sites of inflammation. Among these the chemokine 
receptor CCR6 separates the non-IL-17 producing cells from IL-17 producers. 
Within the CCR6 negative fraction, CXCR3 and CCR4 mark Th1 and Th2 cells 
respectively. In contrast, the CCR6+ cells can be separated into a CCR4+ Th17 
subset and a CXCR3+, IFN- co-expressing Th17+1 population (Acosta-
Rodriguez et al., 2007). Th17 differentiate upon RORt activation in the presence 
of IL-6 and TGFβ and provide immunity against bacteria and fungi in barriers such 
as mucosa and skin while some further develop to IFN- co-expressing Th17+1 
cells in the presence of IL-12 (Lexberg et al., 2010; Yang et al., 2014). 
Furthermore, CCR10 separates an AHR expressing and IL-22 secreting Th22 
fraction from the Th17 population, which are central players in skin protection 
(Fujita, 2013; Trifari et al., 2009; Zheng et al., 2007). These CD4+ T helper 
subsets are complemented by IL-9 secreting, CCR3 expressing Th9 cells that are 
located in mucosa and lung and associated with allergy (Danilova et al., 2015; 
Kaplan, 2013). CD4+ T cells can differentiate into tissue specific populations such 
as T follicular helper cells (TFH) that express CXCR5 and exclusively reside in 
germinal centers to provide B cell help as well as CD103 and/or CD69 expressing 
tissue resident memory cells (TRM), which provide barrier defense (Crotty, 2014; 
Mueller and Mackay, 2016). Natural regulatory T cells (nTregs) derive from the 
thymus or arise in the periphery (“induced” iTregs) by the induction of FoxP3 
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transcription factor. They inherit the ability to suppress unwanted immune 
responses and therefore protect the immune system from autoreactivity (Vignali 
et al., 2008). Some CD4+ T cells exhibit CD8+ associated features such as 
secretion of lytic enzymes (Granzymes, Perforin) together with IFN-. Those 
cytotoxic CD4+ T cells kill the targets cells in a MHCII dependent manner and 
contribute to the defense against intracellular pathogens (Takeuchi and Saito, 
2017). Off note, those classifications are not always strict. For example, some 
Tregs can gain tissue residency by expressing CD103 and/or CD69 (Schenkel 
and Masopust, 2014). Moreover, Tregs as well as TRM were described to secrete 
distinct cytokine profiles that match those of Th1, Th2 or Th17 cells (Hondowicz 
et al., 2016; Wilk et al., 2017). 
 
1.2.8  CD8+ T cells 
In contrast to CD4+ T cells, CD8+ T cells detect antigens presented by MHC type 
I receptors expressed on all nucleated cells. MHCI is presenting cytosolic 
molecules such as virus particles that were degraded by the proteasome, loaded 
onto the MHC in the endoplasmatic reticulum (ER) and transported to the surface. 
CD8+ T cells kill infected target or malignant cells either by secretion of cytolytic 
molecules such as Perforin and Granzymes or by Fas mediated apoptosis (Kägi 
et al., 1994; Lowin et al., 1994; Metkar et al., 2002). The CD8+ T cell compartment 
was diversified into different memory subsets based on the CX3CR1 expression 
as a marker of CD8+ T cell cytotoxicity (Böttcher et al., 2015; Gerlach et al., 2016). 
Alternatively, the markers CXCR3/CCR5 and CCR4/CRTH2/CCR8 known from 
CD4+ T cell subset diversification were used to identify Tc1 (T cytotoxic type 1) 
and Tc2 (T cytotoxic type 2) CD8+ T cells respectively to distinguish IFN- from 
IL-4 producers (Cosmi et al., 2000; D’Ambrosio et al., 1998). Beyond, the usage 
of further receptor combinations remained controversial. IL-17 producing 
CCR5+CCR6+ and a CCR4+CCR5- subset lacking cytolytic molecules and 
secreting IL-4, IFN- and IL-2 instead were described (Kondo and Takiguchi, 
2009; Kondo et al., 2009). Moreover, functional analyses of CD8+ T cell subsets 
indicate the existence of IL-22 producing Tc22 and IL-17/ IFN- coproducing 
Tc17+1 cells (Liu et al., 2011; Yen et al., 2009). Just recently, the complexity of 
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CD8+ T cell compartment was elevated by the introduction and further subdivision 
of skin CD8+ TRM into a CD103+CD49a+ cytotoxic and a CD103+CD49a- non-
cytotoxic subset (Cheuk et al., 2017; Gebhardt et al., 2009; Jiang et al., 2012). 
 
1.2.9  T cell activation  
Proper T cell mediated adaptive immunity requires orchestrated coincidence of 
three independent signals: TCR signaling, costimulatory signal and cytokine 
milieu. The first signal is provided by TCR activation by an MHC presented 
peptide. Additional costimulation, mostly mediated by CD28 which can partially 
be replaced or complemented by CD27, 4-1BB or OX-40, is required to prevent 
anergy and avoid unspecific T cell activation (Chen and Flies, 2013). The tertiary 
signal is provided by the cytokine milieu during activation and guides T cell 
differentiation into a specialized subset to handle the diverse threats. These 
cytokines are usually provided by PRR activated APC but can also derive from 
other lymphoid cells (Curtsinger et al., 1999). 
Optimal CD8+ T cell activation, memory formation and secondary 
expansion is thought to depend on CD4+ T cell help (Bennett et al., 1998; Janssen 
et al., 2003; Schoenberger et al., 1998; Shedlock and Shen, 2003). CD4+ T cell 
help is provided by CD40L dependent DC “licensing” leading to increased antigen 
presentation and expression of costimulatory signals (Frentsch et al., 2005; 
Kawabe et al., 1994). Additionally, activated CD4+ T cells provide IL-2 required 
for optimal clonal expansion and effector function of CD8+ T cells (Lai et al., 
2009).  There are two models how help is provided: the three-cell model that 
requires simultaneous binding of CD4+ and CD8+ T cell to the same APC and the 
sequential two-cell model/kinetic model, that allows a APC licensing by CD4+ T 
cells followed by a later CD8+ T cell activation through the activated APC (Ridge 
et al., 1998). Besides, a variant of “self”-help was also reported for CD8+ T cells. 
Sufficient numbers of activated, IFN- secreting CD8+ T cells activates DC 
detectable by CD80, CD83 and IL-12 secretion (Mailliard et al., 2002, 2013; 
Nakamura et al., 2007; Stark et al., 2013; Wang et al., 2001). Some CD8+ T cell 
clones furthermore produce IL-2 instead of IFN- similar to CD4+ helper cells, 
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which is utilized in an autocrine manner for robust secondary expansion (Feau et 
al., 2011; Mailliard et al., 2013; Pira et al., 2007). 
 
1.3.  CD40L 
CD40L (gp39, CD154, TRAP) is a transmembrane protein of the TNF superfamily 
originally identified in mouse (Armitage et al., 1992). CD40L is expressed on 
activated CD4+ T cells, B cells, monocytes, macrophages, granulocytes but also 
on endothelial cells, epithelial cells, fibroblasts, keratinocytes and platelets 
(Chatzigeorgiou et al., 2009; Grewal and Flavell, 1998). The CD40L protein 
comprises of 32-39 kDa dependent on posttranslational modifications is 
presented as trimeric complex on cell surface or released as soluble form (Graf 
et al., 1995; Mazzei et al., 1995). CD40L is a central player of humoral immunity. 
Activated CD4+ T cells transiently express CD40L and migrate to the boarder of 
the B cell follicles in the lymph nodes. Upon TCR:MHCII interaction they can 
provide CD40L-CD40 mediated co-stimulation and induce germinal center 
formation, somatic hypermutations and class switch in the B cell (Eertwegh et al., 
1993; Foy et al., 1993). Besides, CD40L signaling is a central player of cell-
mediated immunity. CD40L dependent activation can enable B cells, DCs and 
monocytes to mature to highly efficient APCs (Ahmadi et al., 2008; Caux et al., 
1994; Kiener et al., 1995). This CD40L mediated DC “licensing” describes the 
induction of APC maturation processes including the upregulation of MHC and 
costimulatory molecules as well as the secretion of the pro-inflammatory 
cytokines IL-1, IL-6, IL-8 and TNF-α. CD40L-CD40 interaction with DCs moreover 
is necessary to promote IL-12 secretion by the DCs, a cytokine critical for the 
induction of proper cytolytic responses of CD8+ T cells (Fujii et al., 2004).  
 
1.3.1  Structure 
The CD40L gene stretches over 12kb of the X-chromosome and consists of 5 
exons. Gene expression is induced upon TCR stimulation dependent 
translocation of activated transcription factors into the nucleus and binding to 
regulatory elements of the CD40L gene. NFAT was identified as central TF, which 
binds at two sites of the proximal and one site of the distal promotor and is 
supported by CD28 dependent binding of EGR1 (Cron et al., 2006; Lindgren et 
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al., 2001; Lobo et al., 2000; Schubert et al., 1995). The promotor further contain 
a NF-κB (p65 homodimer) binding site, TFE3/TFEB binding sites required for 
maximal activity in mouse, an AKNA binding element and a CD28 response 
element bound by NF-κB and AP-1 components (Huan et al., 2006; Parra et al., 
2001; Siddiqa et al., 2001; Srahna et al., 2001) (Figure 8). CD40L expression is 
further supported by one upstream enhancer with NFAT and GATA3 binding sites 
and a downstream enhancer with a NF-κB (p50 homodimer) binding site (Brunner 
et al., 2008; Schubert et al., 2002). 
 
Figure 8: Location and organization of the CD40LG gene. Adapted from (Steiper et al., 
2008). 
CD40LG is located on the X-chromosome, stretches 12kb and consists of 5 exons that are 
highly conserved among vertebrates. The CD40L promotor inherits binding sites for several 
transcription factors such as NFAT, NF-κB, EGR as well as a CD28 responsive element (RE) 
which are responsible for induction and tuning of CD40L expression. 
 
1.3.2  Regulation 
De novo CD40L expression in CD4+ T cells can be detected as early as 2 hours 
following TCR stimulation, peaks at around 6 hours and is almost undetectable 
after 24 hours (Quezada et al., 2004). Effector and memory CD4+ T cells can 
store CD40L in secretory lysosomes and release as early as 15min following 
activation (Koguchi et al., 2007). In the presence of CD28 and IL-2 signaling, a 
second peak occurs at 48 hours after T cell activation (McDyer et al., 2002; 
Snyder et al., 2007). Prolonged TCR signaling exceeding 24 hours enhances the 
CD40L stability by post-transcriptional mechanisms that influence RNA and 
protein stability and location in human and mouse (Matus-Nicodemos et al., 2011; 
Vavassori et al., 2009). Additionally, IL-15 prolongs CD40L expression in CD4+ T 
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cells in a STAT5 dependent manner (Lowe et al., 2014). However, CD40L surface 
expression is tightly regulated. Interaction with its receptor CD40 leads to 
immediate internalization of CD40L (Kooten and Banchereau, 2000). 
 
1.3.3  Interaction partners 
CD40L has highest affinity to the CD40 receptor, which is expressed 
constitutively or upon activation by most cells of the immune system and the 
vasculature (Schönbeck and Libby, 2001). However, CD40L can also bind αIIbβ3, 
α5β1 and Mac-1 (αMβ2, CD11b) (Alturaihi et al., 2015; Léveillé et al., 2007; Zirlik 
et al., 2007). The three integrins were shown to be bound by the soluble form of 
CD40L. While αIIbβ3 is abundantly expressed on platelets, required for 
aggregation and adhesion was shown to regulate thrombus formation 
stabilization upon CD40L binding, the physiological role of fibronectin receptor 
α5β1 is still unknown (André et al., 2002). In contrast, Mac-1 binding of CD40L 
regulates the migration of leukocytes to sites of inflammation (Wolf et al., 2011; 
Zirlik et al., 2007). 
 
1.3.4  Diseases 
The importance of a tightly controlled CD40L expression is shown by aberrant 
CD40L expression. CD40L deficiency caused by gene mutations in the CD40L 
locus leads to X-linked hyper IgM syndrome characterized by absent class 
switching and consequent lack of IgG, IgA and IgE antibodies but also impaired 
T cell function as an indirect result of absent CD40 mediated activation of DCs 
(Allen et al., 1993; DiSanto et al., 1993). On the other hand, deregulated 
expression levels caused by CD40LG demethylation on the silenced X-
Chromosome was observed in women with systemic sclerosis, systemic lupus 
erythematosus and rheumatoid arthritis leading to increased levels of 
autoantibodies (Lian et al., 2012; Liao et al., 2012; Lu et al., 2007). Increased 
RNA and serum levels of CD40L were detected in multiple sclerosis patients and 
CD40L blockage in murine EAE could prevent disease onset (Gerritse et al., 
1996; Howard et al., 1999; Huang et al., 2000; Zhong et al., 2016). Besides, in 
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several CD40 expressing cancer cell types, dependent on the signaling 
properties, CD40L mediated signaling can result into opposing effects including 
the upregulation of anti-apoptotic factors leading to an increased proliferative 
capacity and survival of the tumor cells but also the induction of apoptosis 
(Elgueta et al., 2009; Frentsch et al., submitted).  
 
1.3.5  CD40L on CD8+ T cells 
A fraction of CD8+ T cell was reported to express the CD4+ helper T cell molecule 
CD40L by us and others (Cronin et al., 1995; Durlanik et al., 2016; Frentsch et 
al., 2013; Hermann et al., 1995; Stark et al., 2013). While around 10% of naïve 
(CD45RA+CCR7+) cells express CD40L, the frequency increases to around 30% 
in the CD45RA- memory compartment (Frentsch et al., 2013). In contrast, none 
of the effector/EMRA (CD45RA+CCR7-) CD8+ T cells can express CD40L. CD8+ 
T cells do not possess prestored CD40L but expression is rapidly activated upon 
polyclonal stimulation and detactable within 2hrs comparable to CD4+ T cells. 
After 3-4hrs the CD40L protein is detectable at the surface, reaching a peak 
between 6-8hrs and slowly declines after 12hrs. CD40L expressing CD8+ T cells 
are capable of DC licensing and B cell activation similar to CD4+ helper cells 
(Frentsch et al., 2013).  
The CD40L+ CD8+ T cell fraction can be subdivided into two populations 
of which the first display weak CD40L expression and classical cytotoxic CD8+ T 
cell properties including the expression of IFN-, Granzymes and Perforin. They 
can be generated in vitro from naïve CD8+ T cells upon stimulation in the 
presence of IL-12 and were found to participitate to in vivo immune responses 
against viruses (human and murine Cytomegalovirus, Epstein-Barr virus, 
Influenza, Yellow Fever) and bacteria (Listeria monocytogenes) (Durlanik et al., 
2016; Frentsch et al., 2013; Stark et al., 2013; AR. Schulz, R.Stark, A.Hartung 
unpublished). CD40L expressed by CD8+ T cells promotes CD4+ memory T cell 
expansion and induces secondary expansion of CD8+ memory T cells 
themselves when inflammation is limited. Recently, Tay et al. showed that the 
observed positive effects on proliferation and secondary expansion of CD8+ T 
cells in defined bacterial and viral infections are mediated by a cell extrinsic 
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positive feedback loop. Activated DC provide IL-12 that induce CD40L in CD8+ T 
cells, which in turn receive proliferation supportive signals via CD40L:CD40 
interaction with the DC (Tay et al., 2017). Besides, CD40L can induce apoptosis 
of CD40 expressing solid tumor cells in a caspase 8 pathway dependent manner 
(Frentsch, Japp et al.; submitted).   
The second fraction of CD40L+ CD8+ T cells is characterized by strong 
CD40L expression (high MFI), lack of cytotoxic molecules and high levels of IL-2 
(S. Warth, unpublished; Frentsch et al., 2013). This CD40L bright population 
resembles CD4+ T cells in their gene expression profile and was shown to be able 
to activate dendritic cells and B cells similar to those classical CD40L+ CD4+ 
helper T cells (Frentsch et al., 2013; Hernandez et al., 2007). However, nor their 
specific role in the immune system neither an induction mechanism could be 
identified for the CD40L bright CD8+ T cells so far.  
 
1.4  Aim of this thesis 
CD40L is a central molecule of activated CD4+ T cell to provide help to B cells 
and induce maturation of APCs whereas CD8+ T cells classically directly kill 
infected or abnormal cells in the body. Previous work could show that CD40L is 
also expressed by some activated CD8+ T cells (Cronin et al., 1995; Durlanik et 
al., 2016; Frentsch et al., 2013; Hermann et al., 1995; Stark et al., 2013). CD40L 
expressing CD8+ T cells have been shown to be involved in the defense against 
various forms of pathogens including viruses, bacteria, parasites and cancer 
cells, of which the vast majority belongs to classical IFN- co-expressing, 
cytotoxic CD8+ T cells that arise upon proliferation in the presence of IL-12 
(Durlanik et al., 2016; Frentsch et al., 2013; Stark et al., 2013; AR. Schulz, 
A.Hartung, unpublished). Those IFN-+ CD8+ T cells differ from a second fraction 
that express high levels of CD40L together with IL-2 and exhibit CD4+ T helper 
like gene expression pattern (Frentsch et al., 2013). However, it is not understood 
how CD40L is induced in those IFN--CD40L+CD8+ T cells and how they 
contribute to the immune defense. Besides, the general mechanism of CD40L 
gene regulation in CD8+ T cell is unknown. Hence, this work aims to investigate 
1) how CD40L expression is regulated in CD8+ T cells on gene level, 2) when 
and where is the CD40L expression induced, 3) what is the impact on immune 
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response. In a first step CD40LG gene locus accessibility, transcription factor 
usage and induction mechanism following TCR activation of CD40L+ CD8+ T cells 
will be compared to common knowledge gathered from CD4+ T cells. Next, this 
work should assess when and in response to what the ability to express CD40L 
is imprinted (or lost) in CD8+ T cells and the resulting implications in the overall T 
cell fate. Finally, the collected knowledge should be placed into the context of 
immune defense and provide a better understanding of the role of CD40L+ CD8+ 
T cells in the periphery. Together, the gathered results should broaden the 
knowledge about the flexibility of the immune system and give useful information 
about the function of CD40L expressing CD8+ T cells resulting into potential 
therapeutic applications of CD40L+ CD8+ T cells. 
M A T E R I A L S  A N D  M E T H O D S  
 
20 
2.  MATERIALS AND METHODS 
2.1  General material and equipment 
2.1.1  Cell culture 
Complete medium for human T cell culture (AB) 
RPMI 1640 – GlutaMAX™       Gibco 
+ Penicillin (100U/ml final)/ Streptomycin (100μg/ml final)  Biochrom 
+ 10% human AB serum, heat inactivated (56°C, 30min)   Pan Biotech 
 
Complete medium for mouse T cell culture 
RPMI 1640 – GlutaMAX™       Gibco 
+ 10% fetal calf serum (FCS), heat inactivated (56°C, 30min) Lonza 
+ Penicillin (100U/ml final)/ Streptomycin (100μg/ml final)  Biochrom 
+ 50μM β-Mercaptoethanol      Gibco 
 
ACK lysing buffer        Gibco 
Trypsin/EDTA solution (0.05%/0.02%)     Biochrom 
 
2.1.2  Buffers 
dH2O (desalted)        House made 
PBS (phosphate buffered saline)      Gibco 
 
PBS 
+ BSA (bovine serum albumin, 0.2% final)    PAA 
 
TAE buffer: dH2O 
+ 40mM Tris (pH 7.6)      Roth 
+ 20mM acetic acid       Sigma 
+ 1mM EDTA       AppliChem 
 
2.1.3  Chemicals 
Isopropanol        Merck 
Ethanol        Roth 
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Methanol        Merck 
Natrium hydroxide (NaOH)     Roth 
Hydrochloric acid (HCl)      Roth 
 
2.1.4  Material 
Conical tubes (15ml and 50ml)     Corning 
Cell strainer (40μm and 70μm)     BD Bioscience 
CellTris filter (30μm)      Partec 
Cell culture plates (96/48/24/6 well)    Greiner Bio-one 
Cell culture dish       Greiner Bio-one 
Cell culture flasks (T25 and T75)     Corning 
Syringes        BD Bioscience 
Vacutainer blood collection tubes (Lithium Heparin)  BD Bioscience 
 
2.1.5  Equipment 
Allegra X-15R Centrifuge      Beckmann Coulter 
Allegra X-22 Centrifuge      Beckmann Coulter 
Centrifuge 5810R       Eppendorf 
Microfuge16        Beckmann Coulter 
Microfuge22R       Beckmann Coulter 
Vacuum pump (BVC21)      Vacuubrand 
Vortexer (Genie2)       Scientific Industries 
CASY Cell counter       Innovartis 
CO2 Incubator       New Brunswick  
Water bath        GFL 
Pipettes        Eppendorf 
MasterCycler personal      Eppendorf 
Thermomixer comfort      Eppendorf 
Mini Shaker        VWR  
Innova44        New Brunswick 
ND-1000        NanoDrop Tech. 
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2.2  Cell culture methods 
2.2.1  Preparation of human peripheral blood cells (PBMCs) 
All experiments involving human material were approved by the Ethics committee 
of the Charité. 
Tested buffy coats were obtained from DRK-Blutspendedienst Nord-Ost. Venous 
blood was collected in Vacutainer Lithium Heparin blood collection tubes (BD 
Bioscience) from healthy volunteers or SLE patients after informed consent.  
If HLA information was required, 50µl of whole blood was diluted 1:1 with 
PBS/BSA and stained with HLA-A2 antibody for 15min at RT prior to erythrocyte 
lysis with 1ml Buffer EL (Quiagen) for 15min on ice. After washing with PBS/BSA, 
HLA status was assessed by flow cytrometry. 
For PBMC isolation, whole blood was diluted 1:1 with PBS/BSA and overlaid to 
1/5th volume Ficoll (Biocoll separating solution, Biochrom). After centrifugation 
(20min, 800g, acceleration: 7, deceleration: 1) the white interphase was collected 
and washed with PBS/BSA (10min, 490g). After resuspending in PBS/BSA, cells 
were counted (CASY, Innovatis) and centrifuged (10min, 300g) before further 
processing. 
Human cells were cultivated in RPMI (Gibco) supplemented with 10% AB Serum 
(Pan Biotec) and 1% Penicillin (100U/ml final)/Streptomycin (100µg/ml final, both 
Biochrom).  
 
2.2.2  Preparation of human thymus 
Human thymi were provided from Deutsches Herzzentrum Berlin (DHZB), Berlin 
after surgical removal during heart operation of children <12 months of age. 
Thymi were sliced into smaller pieces and reduced to single cell suspension by 
passing through a 70μm cell strainer using the plunger of a syringe while washing 
with PBS/BSA. After centrifugation and resuspension, the cells were passed 
through a 30μm filter before cultivation in complete human T cell medium or flow 
cytometric staining and analysis. 
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2.2.3  Isolation of murine cells  
C57BL/6, MHCI KO and MHCII KO mice (on C57/BL6 background) were obtained 
from the Jackson Laboratory. OT-I mice were kindly provided by Thomas 
Blankenstein (MDC) and CD8+ specific H-Y (Mata Hari) mice from Il-Kang Na 
(MDC/Charité). 
All mice were bred, housed and used at the Charité in accordance with the 
German law for animal protection with permission from the local veterinary offices 
and the LAGeSo (Landesamt für Gesundheit und Soziales), Berlin. Genotypes of 
transgenic animals were analyzed routinely by PCR or flow cytometry before use. 
Mice were anesthetized with Isoflurane (AbbVie) prior to sacrificing by cervical 
dislocation. The fur was disinfected with ethanol followed by removal of the 
thymus and spleen and transfer into PBS/BSA. The organs were passed through 
a 70μm cell strainer using the plunger of a syringe to gain single cell suspensions. 
After centrifugation (5min, 350g) the supernatant was discarded and splenocytes 
were resuspended in 1ml ACK buffer (Gibco) for 3min at RT for the lysis of 
erythrocytes. Lysis was stopped with PBS/BSA followed by centrifugation (5min, 
350g). For all further steps cells were passed thorugh a 30μm filter and kept in 
PBS/BSA or cultivated in mouse medium containing RPMI 1640 (Gibco) 
supplemented with 10% fetal calf serum (FCS, heat inactivated 56°C, 30min, 
Lonza), Penicillin (100U/ml final)/ Streptomycin (100μg/ml final, both Biochrom) 
and 50μM β-Mercaptoethanol (Gibco). 
 
2.2.4  Cell counting 
Cells were counted by mixing a defined volume of cell suspension with 
appropriate electrolytic buffer (CASYton, Roche) and measurement at CASY 
(Roche/Innovartis). CASY works with a low voltage field applied to a pore that is 
filled with the cell suspension. Particles in the electrolyte solution cause a 
measurable increase in resistance dependent on their diameter used to 
distinguish cell numbers and debris. From given cell numbers, total cell counts 
were calculated. 
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2.2.5  Magnetic cell enrichment 
For enrichment of defined populations prior to flow cytometric sorting or other 
applications supramagnetic nanoparticels bound to antibodies were applied 
(MACS, Miltenyi Biotech). Cells were labelled with appropriate MicroBead-
conjugated antibodies 15min at RT. After washing with PBS/BSA (5min, 350g) 
cells were applied through a 30μm filter to a MACS column (Miltenyi Biotec) 
bound to a magnetic field. The ferromagnetic matrix of the columns binds 
MicroBead labeled cells while all unbound cells were washed away with 
PBS/BSA. After washing, the column was removed from the magnetic field and 
cells were eluated from the column with 5ml PBS/BSA. For up to 1x107 magnetic 
labelled or up to 2x108 total cells, MS columns were used. For larger quantities, 
LS columns were applied. MACS technology was utilized for the enrichment of 
CD4+ and CD8+ T cells respectively.  
 
2.2.6  Cell stimulation 
Characterization of cytokine profiles or CD40L expression a well as cell 
expansion required activation of the T cell cells. For maximal cytokine/CD40L 
readout, polyclonal stimulation was applied using chemical compounds phorbol 
12-myristate 13-acetate (PMA, Sigma) and Ionomycin (Iono, Sigma) that mimic 
TCR- plus co-stimulation. Both activate the protein kinase C, a central player of 
intracellular TCR signaling. Furthermore, Ionomycin induces activation of NFAT 
by promoting influx of calcium into the cytosol. For stimulation, 1-2x106 cells/ml in 
medium were supplemented with 10ng/ml PMA and 1μg Iono for 6hrs at 37°C in 
the incubator (5% CO2, >90% relative humidity). 
More physiological stimulations as well as long term cultures were achieved with 
αCD3/αCD28 stimulations. 1µg/ml αCD3ε antibody (UCHT1, BD) and 3µg/ml 
αCD28 antibody (CD28.2, BD) (if not stated otherwise) were loaded onto 96 well 
plates (PS U plate, Greiner Bio-one) in PBS and incubated for 2hrs at 37°C or 
O/N at 4°C. Unbound antibodies were washed away with PBS. 1x105 cells in 
100µl AB medium were stimulated per well for 6 hours (short term stimulation).  
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Human thymocytes were stimulated with a combination of superantigens 
Staphylococcus aureus enterotoxin B (SEB) and Toxic shock syndrome toxin 1 
(TSST1). Superantigens bridge the binding of TCR and MHC in a peptide 
independent manner. Thymocytes were stimulated at 2x106 cells/ml with 1.5 
μg/ml SEB (Sigma-Aldrich) and 1μg/ml TSST1 (Sigma-Aldrich) for 6hrs at 37°C 
in the incubator (5% CO2, >90% relative humidity). 
 
2.2.7  Cell cultivation (long term) 
For CD40L stability experiments and T cell priming, long term culture was applied. 
Sorted human naïve/memory CD8+ T cells or SP CD8+ thymocytes were loaded 
at 5x104-1x105 cells/well in human complete culture medium supplemented with 
various cytokines (10ng/ml, see Table 2) into αCD3/αCD28 coated 96 well plates. 
After 2 days incubation at 37°C in the incubator, the cells were transferred into 
an uncoated 96 well plate and incubated for further 5 days with additional cytokine 
supplemented medium. If needed, cells were transferred into larger wells with 
higher volumina of medium. At day 7 cells were removed from the plates, counted 
and re-stimulated with PMA/Iono for 6hrs for CD40L/cytokine readout. 
Cytokine Manufacturer 
 
IL-2 IS  Miltenyi 
IL-7 Miltenyi 
IL-12 Miltenyi 
IL-15 Miltenyi 
IL-18 MBL 
Table 2: Cytokines and blocking antibodies used in long term cultivation 
 
2.3  Flow cytometry and fluorescence-activated cell sorting 
(FACS) 
Fluorescence based flow cytometry allows high throughput characterization of 
cells on single cell basis by fluorophores bound to cells. Those fluorophores can 
be coupled to specific antibodies against defined proteins, intercalate with DNA 
(DAPI/Propidium iodide) or bind to amine groups of cells (CFSE). An accordingly 
stained cell suspension is diluted with sheath fluid to single cell level while running 
through a laser beam. The forward scatter measures the distraction of the laser 
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beam and correlates with cell diameter while the side scatter detects cell 
granularity. The laser beam furthermore excites fluorophores bound to the cell. 
The emitted fluorescence signal is amplified and run through different dichroic 
filters to separate detectors allowing the measurement of several fluorophores at 
the same time.  
The cells were measured with FACSCantoII (BD Bioscience) or LSRII (BD 
Bioscience) and analyzed with FlowJo software (Treestar). For cell sorting, a 
FACSAriaII Machine (BD Bioscience) was used by the Flow Cytometry core 
facility of the BCRT. 
Instrument Laser Detectors BP filters 
FACSCantoII  405nm 450/50; 510/50 
 488nm 488/10; 530/30; 585/42; 
670LP; 780/60 
 633nm 660/20; 780/60 
LSRII 405nm 450/50; 525/50; 610/20; 
710/50; 780/60 
 488nm 488/10; 525/50; 685/35 
 561nm 582/15; 610/20; 670/14; 
710/50; 780/60 
 640nm 660/13; 720/30; 780/60 
Table 3: Configurations of the flow cytometers 
 
2.4  Immonofluorescence staining 
2.4.1  Surface staining 
Cells were stained in 100ul PBS/BSA with fluorophore coupled antibodies plus 
Fc receptor antibodies to prevent unspecific binding for 10min at RT in the dark. 
For human cells, Beriglobin (1mg/ml, CSL Behring) was used as Fc block; mouse 
cells were supplemented with FcR antibody (2ug/ml, DRFZ). All antibodies were 
titrated to determine their optimal concentration prior to use. After staining, cells 
were washed with 4ml PBS/BSA to reduce background and spun down 350g, 
5min. Prior to flow cytometric measurement, DAPI (0.4µM) or PI (0.4mg/ml) were 
added to detect dead cells. 
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For the surface detection of CD40L the stimulation was performed in the 
presence of antibodies against CD40 to prevent internalization of CD40L (Yellin 
et al., 1994). 
Antibody Clone Final conc. Manufacturer 
CD40 (human) G28-5 3g/ml DRFZ 
CD40 (mouse) FGK-45 3g/ml DRFZ 
Table 4: Antibodies for surface detection of CD40L 
 
2.4.2  Intracelluar staining  
For detection of secretory proteins such as cytokines Brefeldin A (10µg/ml final, 
Sigma) was added during stimulation to prevent a release from the Golgi 
complex. Detection of intracellular proteins requires fixation and permeabilization 
prior to staining. This was accomplished by washing with PBS after the 
stimulation followed by LiveDead™ staining (1µl/ml final, ThermoFisher) for 
20min. During the last 10min, surface markers were added. After washing with 
PBS/BSA, 5min, 350g cells were fixated with 1ml 1:10 diluted in H2O BD Lysing 
solution (BD Bioscience) for 10min at RT followed by centrifugation 5min, 350g. 
The supernatant was discarded and cells were resuspended in 500ul BD 
Permeabilization solution 2 (diluted 1:10 in H2O, BD Bioscience) for 10min, RT. 
After washing with PBS/BSA, cells were stained intracellularly with appropriate 
antibodies for 30min at RT in the dark, washed and measured on a flow 
cytometer.  
 
2.4.3  Intracellular staining of phosphorylated transcription factors 
Cells were stimulated 13min with PMA/Ionomycin, washed at 350g, 5min and 
fixated with 16% PFA (paraformaldehyde, ThermoFischer) for 10min. After a 
second washing step, surface staining was applied for 30min prior to 
permeabilization with 600µl Methanol (Sigma) over night at -80°C. Staining of 
phosphorylated transcription factors was applied for 30min at RT prior to flow 
cytometric measurement. 
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2.4.4  Intranuclear staining 
Detection of transcription factors was done separately with specific nuclear factor 
fixation and permeabilization solutions. Cells were stained with LiveDead™ and 
surface markers as indicated above followed by fixation with 1ml Nuclear Factor 
Fixation buffer (diluted 1:4 in PBS, Biolegend) for 20min at RT. Following washing 
with 1ml Nuclear Factor Permeabilization buffer (diluted 1:10 in PBS, Biolegend) 
the cells were incubated in 1ml Permeabilization buffer for 20min. After 
centrifugation and discarding the supernatant, the cells were stained for 
intranuclear factors 30min at RT in the dark prior to measurement. 
Intranuclear FoxP3 stainings were conducted for 30min in 100µl FoxP3 Perm 
solution after treatment of the cells with 1ml 1x Biolegend FoxP3 Fix/Perm 
solution (diluted in PBS) for 20min, followed by a washing step with 1ml 1x FoxP3 
Perm buffer (diluted in PBS, Biolegend) and further 15min incubation in 1ml 
FoxP3 Perm buffer. 
 
2.4.6  Antibodies 
Following antibodies were titrated for their optimal concentrations and used for 
cell labelling in human and mouse:  
Human 
Antigen Clone Manufacturer 
CD3 OKT3/UCHT-1 Biolegend/House made 
CD4 RPA-T4 Biolegend 
CD8 RPA-T8 BD 
CCR7 G43H7 Biolegend 
CD45RA HI-100 Biolegend 
CD45RO UCHL1 Biolegend 
CCR4 L291H4 Biolegend 
CCR6 G034E3 Biolegend 
CCR10 6588-5 Biolegend 
CXCR3 G025H7 Biolegend 
CD40L 34-31 Biolegend 
IFN- B27 Biolegend 
IL-2 MQ1-17H12 Biolegend 
IL-4 MP4-25D2 Biolegend 
IL-22 22URTI eBioscience 
IL-17A BL168 Biolegend 
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SLAMF7 162.1 Biolegend 
Granzyme B GB11 BD 
Perforin B-D48 abcam 
CD1a HI149 BD 
Runx3 527327 R&D 
ThPOK 11H11A14 Biolegend 
AHR FF3399 eBioscience 
GATA3 REA174 Miltenyi 
NFκB p65 K10-895.12.50 BD 
HLA-A2 BB7.2 Biolegend 
CD5 UCHT2 Biolegend 
CD69 FN50 Biolegend 
CD56 HCD56 Biolegend 
CD25 M-T271 BD 
FoxP3 259D/C7 BD 
CD11a HI11 Biolegend 
CD95 DX2 Biolegend 
CD28 CD28.2 Biolegend 
CD103 Ber-ACT8 Miltenyi 
CD57 HCD57 Biolegend 
CLA HECA-452 Miltenyi 
Table 5: Human antibodies 
 
Mouse 
Antigen Clone  Manufacturer 
CD3 145-2C11 Miltenyi 
CD4 GK1.5 Miltenyi 
CD8 53-6.7 Biolegend 
CD24  M1/69 Biolegend 
CD25 PC62 Biolegend 
CD44 IM7 Biolegend 
CD5 53-7.3 Biolegend 
CD40L MR1 Miltenyi 
Table 6: Mouse antibodies 
 
2.5  Multiplex ELISA 
For quantification of secreted cytokines, sorted CD8+ and CD4+ T cell subsets 
were cultivated at 1x104 cells/100µl AB medium in αCD3/αCD28 coated 96 well 
plates for 24hrs or 72hrs. Pooled supernatants were snap frozen in liquid nitrogen 
(N2) and stored at -80°C until further use. Multiplex ELISA (Q-Plex™ Array, 
Quansys) was performed with 50µl supernatant according to the manufacturer’s 
protocol. Infrared emission was analyzed with Odyssey (LiCor) at various 
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intensities. Data analysis was performed with Q-view software (version 3.09, 
Quansys).  
 
2.6  Keratinocyte Activation Assay 
Cytokine supernatants of sorted T cells as described in Multiplex ELISA or 
medium alone were applied at 2% final concentration to primary human 
keratinocytes (CellSystems) cultured in KGM medium (Lonza) and incubated for 
further 24hrs. Cells were harvested, RNA isolated and activation assessed by 
RT-qPCR conducted by K. Wolk, Charité. Reverse transcription of mRNA was 
performed after preincubation of 25 μg/μl total RNA of each sample with 16 ng/μl 
oligo d(T)18 primer (ThermoFisher Scientific) at 75 °C for 5 min followed by 
cooling in an ice bath. 5U/μl M-MLV reverse transcriptase, first strand buffer, 
10 mM DTT (all from ThermoFisher Scientific), 2U/μl of RNasin ribonuclease 
inhibitor (Promega) and 250 mM of ultrapure dNTP Set (Merck) were added and 
the reaction conducted at RT for 10min followed by 42°C step for 60min and a 
reaction stop at 95°C, 5min. Triplicates of each sample were analyzed by 
quantitative real-time PCR (StepOne plus, ThermoFisher scientific) using 
Maxima Probe/ROX qPCR Master Mix, ready-to-use detection assays for CCL26, 
CXCL11 and the house keeping gene HPRT containing double-labeled probes 
(all ThermoFisher Scientific). Gene expression was calculated relative to HPRT 
expression. 
 
2.7  Quantitative real time PCR 
Cells of interest were resuspended in 350µl lysis buffer RA1 (Macherey&Nagel) 
containing 1% β-Mercaptoethanol (Sigma), snap frozen in liquid N2 and stored at 
-80°C until further use. RNA was isolated with NucleoSpin RNA Isolation kit 
(Macherey & Nagel) according to the manufacturers’ protocol. The quality of total 
RNA isolates was quantified using a NanoDrop ND-100 spectrophotometer and 
normalized with qPCR grade H2O. Reverse transcription of RNA to cDNA was 
performed with TaqMan reverse transcription kit (Applied Biosystems). 7.7µl RNA 
was mixed with 2µl TaqMan reaction buffer (10x), 4.4µl MgCl2 (25mM), 4µl 
dNTPs, 0.5µl random hexamers, 0.5µl oligo (dT), 0.4µl RNAse Inhibitor and 0.5 
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µl reverse transcriptase to 20µl total volume. Reverse transcription was 
performed at 10min 25°C, 40min 48°C, 5min 95°C followed by cooling to 4°C.  
For quantitative analysis of RNA expression levels TaqMan qPCR was performed 
with cDNA. TaqMan technology bases on probes that bind the cDNA between 
the primer binding sites. Probes are small stretches of complementary sequences 
with a fluorophore and a quencher bound to its opposite ends. The quencher 
suppresses fluorescence by FRET (Forester Resonance Energy Transfer) until 
amplification of the cDNA leads to dissociation and cleavage of the probe 
accompanied by a local separation of fluorophore and quencher resulting in 
detectable fluorescence. The additional need for binding to complementary 
sequences by the probe reduces possible off target effects compared to 
quantification with classical DNA intercalating fluorescence reagents such as 
SYBR Green. All primers were designed intron spanning to avoid amplification of 
genomic DNA and obtained from TIB MolBiol. Probes with FAM fluorophore and 
Dark quencher were obtained from Roche. Optimal concentrations of primers and 
probe were assessed prior to use. 5µl of cDNA was added to a total volume of 
15µl qPCR mix containing 2µl 10x concentrated primer/probe mixture, 3µl qPCR 
grade H2O (Roche) and 10µl LightCycler MasterMix (2x, Roche) into a 384 well 
plate (Roche). qPCR was run with a pre-incubation stage 5min, 95°C; 45 cycles 
of amplification with 10sec 95°C, 30sec 60°C, 1sec 72°C and a cooling phase for 
10sec 40°C using a LightCycler® 480 II (Roche). All samples were run in 
duplicate and normalized to the housekeeping gene ACTB. Data analysis was 
performed with LightCycler® 480 Software (Version 1.5, Roche).  
Primer Sequence 5´-> 3´ Probe number 
(Roche) 
ACTB fwd ATTGGCAATGAGCGGTTC 11 
ACTB rev CGTGGATGCCACAGGACT 11 
CD40L fwd TCATGAAAACGATACAGAGATGC 2 
CD40L rev CTTCGTCTCCTCTTTGTTTAACATT 2 
Table 7: Primers and Probes used for quantitative real time PCR 
 
2.8  RNA-sequencing 
RNA was isolated from sorted cells with NucleoSpin RNA Isolation kit (Macherey 
& Nagel) according to the manufacturers’ protocol. The quality of total RNA 
isolates was quantified using a NanoDrop ND-100 spectrophotometer and 
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integrity further analyzed using the Agilent RNA 6000 Nano kit with Agilent 2100 
Bioanalyzer. Following RNA-sequencing was conducted by the BCRT Next 
Generation Sequencing Core Facility. In detail, Poly-(A)-selection was performed 
utilizing the NEBNext Poly(A)mRNA Magnetic Isolation Module (NEB) according 
to the manufacturers requirements. mRNA libraries were prepared with the 
NEBNext Ultra RNA Library Prep Kit for Illumina (NEB). All libraries were 
analyzed with the Agilent DNA 1000 Kit and quantified using the Qubit® dsDNA 
BR Assay Kit (ThermoFisher). After equimolar pooling all samples were 
sequenced using an Illumina HiSeq 1500 system with High Output chemistry v4 
(50 cycles, single-read). The RNA-sequencing data is deposited and accessible 
at NCBI GEO Expression Omnibus under: GSE115103. 
Raw data were quality controlled by fastQC and reads were aligned to the 
GRCh37 (Ensembl) human genome using bowtie2 (Langmead and Salzberg, 
2012). Reads were summarized per gene using the featureCount algorithm 
implemented in the R-package "Rsubread" and the further processing and 
analysis of the sequencing data were done in R (version 3.3.3). Raw counts of 
protein coding genes were normalized and transformed. The combat algorithm 
(package "sva") was used to remove variances in gene expression which were 
associated with the CD4-CD8 contrast only and donor specific differences (Leek 
et al., 2012). Therefore, CD4 or CD8 samples were combined with the donor id 
and used as batch definition. Top 1000 most variable expressed genes across all 
samples of either non-compensated or compensated data were used to generate 
heatmaps of unsupervised hierarchical clustering (euclidean distances of scaled 
data and complete linkage). 
Principal component analysis (PCA): Normalized and compensated data for all 
genes were scaled and subjected to a principle component analysis using 
singular value decomposition. The first two principle components were shown in 
the plot. Signature genes distinguishing the cell subsets were identified by fitting 
generalized linear multinomial models to the normalized data via penalized 
maximum likelihood (package "glmnet"). RNA-seq data for dermal and epidermal 
T cell subsets were obtained from GEO database (GSE83637). Raw counts were 
combined with raw expression data from this study, normalized and variance 
stabilized transformed (package "DESeq2"). In order to remove technical 
differences between the two studies, a batch compensation using the donor ids 
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as batch definition was done (package "sva"). Top 1000 most variable expressed 
genes across all samples from this set were used in a principle component 
analysis. PC1 and PC2 were displayed in the plot. Overrepresentation of genes 
related to specific GO terms were analyzed using the topGO package with all 
protein-coding genes as background.  
 
2.9  TCR-sequencing 
Analyses of TCR repertoires was performed by next generation sequencing of 
CDR3 beta chain as described previously (Bacher et al., 2016; Dziubianau et al., 
2013). Genomic DNA was isolated from FACS sorted Tc subsets using AllPrep 
DNA Micro Kit (Qiagen) followed by recombined TCR-β locus amplification with 
Multiplex PCR Kit (Quiagen) and sequencing with the Illumina MiSeq System. 
The primary analysis of raw sequencing data including subsequent clone 
grouping and clonotype generation was performed as previously described using 
the free open-source clonotyping IMSEQ analytic platform (Kuchenbecker et al., 
2015). Reads with an average quality score below 30 were excluded from the 
analysis. 
Shared clonotypes and shared reads were calculated as in (Becattini et al., 2015). 
Shared clonotypes were assessed using the Jaccard index defined as: (shared 
clonotypes of 1 and 2)/(total clonotypes1 + total clonotypes2 - shared clonotypes 
of 1 and 2). To calculate shared reads, the frequency of shared clonotypes within 
total reads was assessed from population 1 with population 2 and other way 
round. Mean values were plotted.   
 
2.10  TREC quantification 
TREC numbers were quantified by C.Schmidt, Universität Greifswald using a 
TaqMan qPCR with an ABI PRISM 7700 Sequence Detector Taqman (Thermo 
Fisher) as described in (Kimmig et al., 2002). In brief, qPCR was performed with 
100ng genomic DNA, using a serial dilution of an RAG2 and δRec-ϕJα signal joint 
(TREC) expressing vector as standard curve. DNA, 10nM dNTP (PerkinElmer), 
PCR buffer including 4.5mM MgCl2 (Life Technologies), 1.25 U PlatiniumTaq 
polymerase (Life Technologies), 25 pmol of primers and 5pmol 6FAM-TAMRA 
probe were used in 50µl total volume for amplification. After initial denaturation 
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step at 95°C for 5min, 45 cycles of 95°C, 30sec and 66°C, 30sec were performed. 
For TREC analysis the primers ϕJα (-258): AAC AGC CTT TGG GAC ACT ATC 
G, δRecsj (+104): AAC AGC CTT TGG GAC ACT ATC G and the probe: 6FAM-
CCA CAT CCC TTT CAA CCA TGC TGA TGA CAC CTC T-TAMRA were used. 
For RAG2 analysis the primers RAG2 (2160) GCA ACA TGG GAA ATG GAA 
CTG, RAG2 (2404) GGT GTC AAA TTC ATC ATC ACC ATC and the probe 
6FAM-CCC CTG GAT CTT CTG TTG ATG TTT GAC TGT TTG TGA-TAMRA 
were utilized. 
 
2.11  DNA Methylation analysis 
Genomic DNA was isolated with the DNeasy tissue kit (Quiagen) according to the 
manufacturers protocol and applicated to bisulfite treatment by Epiontis as 
described in (Olek et al., 1996). Sodium bisulphite treatment leads to conversion 
of unmethylated cytosines into uracil that is detected as thymine in following PCR 
whereas methylated cytosines remain unchanged. The PCR products were 
purified with ExoSAP-IT (USB Corp.) and sequenced using the ABI Big Dye 
Terminator v 1.1 chemistry (Applied Biosystems) followed by capillary 
electrophoresis on an ABI 3100 genetic analyzer. The data was interpreted with 
ESME (Lewin et al., 2004).   
 
2.12  Statistics 
Statistical analysis was conducted with Prism (Version 7, GraphPad Software) as 
specified in text and figure legends. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
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3.  RESULTS 
3.1  TCR dependent induction of CD40L gene expression  
3.1.1  NFAT but not NF-κB is essential for CD40L expression  
It is not understood why all CD4+ but only some CD8+ T cells are capable to 
express CD40L upon T cell activation. One possibility is a difference in CD40L 
gene expression induction between CD40L- and CD40L+ T cells. Gene 
expression is regulated by a vast interplay of transcription factors that bind to 
regulatory elements within and around gene loci and control induction as well as 
repression of the gene. CD40L expression in CD4+ T cells is induced by TCR 
dependent T cell activation, which has been shown to be critically dependent on 
the transcription factors NFAT and NF-κB (Brunner et al., 2008; Lobo et al., 2000; 
Schubert et al., 1995). TCR ligation activates an intracellular signaling cascade 
resulting into a calcium (Ca2+) flux into the cell (Figure 9).   
 
Figure 9: T cell activation is translated into de-phosphorylation (P) of NFAT and 
phosphorylation of NF-κB by intracellular signaling cascades allowing the 
translocation into the nucleus and induction of CD40L expression.  
 
This cascade can be supported by a parallel activation of the T cell co-receptor 
CD28 (Andres et al., 2004). Intracellular calcium forms a complex with calmodulin 
which in turn activates calcineurin (CaN). The active form of calcineurin 
dephosphorylates cytosolic NFAT leading to the translocation of NFAT into the 
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nucleus and subsequent binding to CD40LG locus (Brunner et al., 2008; Lobo et 
al., 2000; Macian, 2005; Schubert et al., 1995). 
In a first step, we assessed whether CD8+ T cells utilize the same 
mechanisms of CD40L gene expression induction as known from CD4+ T cells. 
We analyzed the role of NFAT for CD40L induction in CD8+ T cells by an inhibition 
of the calcineurin phosphatase activity with Cyclosporine A (CsA) (Clipstone and 
Crabtree, 1992; Mattila et al., 1990). CsA was shown to be an efficient inhibitor 
of CD40L in CD3+ T cells (Fuleihan et al., 1994). By subdividing the CD3+ fraction, 
we could show that CsA efficiently abolishes CD40L expression in polyclonally 
activated CD8+ T cells at concentrations of 12.5 nM comparable to CD4+ T cells 
(Figure 10A). Strong inhibitory effects of CsA were also observed for IFN- and 
IL-2 production.  
NF-κB, the second central TF in the induction of CD40L expression is also 
activated by TCR signaling and binds to the CD40LG promotor and the 
downstream enhancer as p65 homo- or p50/p65 heterodimer (Schubert et al., 
2002; Srahna et al., 2001). In resting cells, bound IκB kinase keeps NF-κB dimers 
in the cytosol. Following TCR activation, phosphorylation of the IκB kinase 
releases NF-κB to translocate into the nucleus (Karin, 1999). As CsA is shown to 
affect not only NFAT but also NF-κB, we used ML120B to assess the effect of 
NF-κB specific inhibition on CD40L expression (Nishiyama et al., 2005; Srahna 
et al., 2001). ML120B is a potent and highly selective IκB Kinase β-inhibitor that 
exhibit an IC50 (half maximal inhibitory concentration) value of 3.4µM assessed 
by IL-2 inhibiton in activated human PBMCs (Nagashima et al., 2006; Wen et al., 
2006). Despite we observe reduced levels of IL-2 and efficient block of p65 
phosphorylation, ML120B treatment did not affected CD40L expression in 
activated CD4+ or CD8+ T cells (Figure 10B, C). In order to exclude possible non-
physiological effects of the strong, chemical stimulus with PMA and Ionomycin, 
the inhibition experiments were repeated with plate bound αCD3/αCD28, 
resulting in the same result (not shown).  
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Figure 10: Role of NFAT and NF- κB in the induction of CD40L expression in CD4+ and 
CD8+ T cells. 
CD4+ and CD8+ T cells were enriched from human PBMCs by MACS. Cells were treated with 
12.5nM CsA (A), 4µM ML120B (B) or according concentrations of DMSO for 45min prior to 
polyclonal stimulation with PMA/Iono for 6hrs in the presence of BrefA. Cytokines were 
stained intracellularly and measured on a flow cytometer. Data is summarized from three 
independent experiments. Mean ± SEM, Student`s t-test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
(C) Enriched CD8+ T cells were stimulated with PMA/Iono for 13 min prior to fixation followed 
intranuclear staining for phosphorylated p65 NF-κB subunit and measurement on a flow 
cytometer.  
 
In summary, the induction of CD40L by TCR stimulation via the activation and 
subsequent binding of NFAT to the CD40LG locus is equally important in CD4+ 
as well as CD8+ T cells, whereas the contribution of NF-κB is neglectable in both 
cell types. 
 
3.1.2  Identification of potential regulatory elements at the CD40LG locus 
While NFAT is indispensable for CD40L induction in CD4+ as well as CD8+ T 
cells, it remains unclear why the majority of CD8+ T cells is incapable to express 
CD40L. Another mechanism of gene expression regulation are epigenetic 
modulations including DNA methylation and histone modifications. Interestingly, 
aberrant DNA demethylation of the CD40LG promotor accompanied by de-
regulated CD40L expression was observed in several autoimmune disorders 
(Belkhir et al., 2014; Lian et al., 2012; Liao et al., 2012; Lleo et al., 2012; Lu et 
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al., 2007). Hence, we hypothesized that DNA methylation might be a central 
regulator of CD40L expression in T cells. DNA methylation describes the active 
addition of a methyl group to a cytosine within a CpG element by DNA 
methyltransferases (DNMTs). Cytosine methylation affects the binding sites of 
transcription factors and generally results in a blockage of gene expression (Zhu 
et al., 2016).  
 
So far, the DNA methylation analyses of the CD40LG locus were limited 
to the promotor of CD4+ T cells and from transcription factor analyses two 
enhancers were described as additional regulatory elements of CD40L 
expression. However, all CD4+ T cells are homogenously capable of expressing 
CD40L in contrast to CD8+ T cells. Therefore, we cannot exclude the possibility 
that CD8+ T cells use other/additional regulatory elements. In order to identify 
possible further regulatory elements, we performed an extensive in silico 
comparative sequence analysis stretching +/- 100kb around the CD40LG gene, 
which would include possible long distance enhancers (Figure 11) (Chepelev et 
al., 2012). Orthologous sequences of human and mouse were aligned and coding 
as well as non-coding sequences with a homology >75% identified in mVISTA 
(Mayor et al., 2000). Next, we scanned the identified homologous sequences for 
conserved transcription factor binding sites with a focus on those transcription 
factors known to regulate CD40L expression (see 1.3.1) in rVISTA (Loots et al., 
2002). As sites of gene expression and gene regulation furthermore exhibit an 
uncoiled, open chromatin formation, they are more susceptible to DNAse I 
dependent digestion (Crawford et al., 2006). We utilized published data of DNAse 
I hypersensitive sites gained from CD40L expressing cells such as Th1 CD4+ 
cells (GEO: GSM1008604), EBV transformed lymphoblastoid cell line (Cell line 
GM12878, GEO: GSM816665) and Jurkat cells (Clone E61, GEO: GSM736501) 
and overlaid them with the TF binding sites (Boyle et al., 2008; Imadome et al., 
2003).  
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Figure 11: Identification strategy of potential regulatory elements within and around 
the CD40LG locus.  
 
Potential regulatory elements of the CD40LG locus were identified by an overlay of high 
homologous sequences between human and mouse (mVISTA) with transcription factor 
binding sites (rVISTA) and DNase I hypersensitive sites from CD40L expressing CD4 TH1, 
Jurkat and EBV transformed B-cells. Besides the known regulatory elements promotor, 3´-
enhancer and 5´-enhancer (black boxes), two intragenic candidates at -8kb and -10kb (red 
boxes) are shown.  
 
The combination of these approaches identified two intragenic, intronic (at -8kb 
and -10kb) (Figure 11) and four extragenic sequences (at +35kb, +17kb, -20kb 
and -27kb) (not shown) as potential regulatory elements beyond the published 
promotor and two enhancers. These regions were finally assessed for the 
presence of CpG sequences before they were included in the DNA methylation 
analysis.  
 
3.1.3  CD40L expression correlates with DNA demethylation  
DNA methylation and demethylation are transient processes in T cell maturation, 
differentiation and division (Berkley et al., 2013; Thomas et al., 2012; Tsagaratou 
et al., 2017). Therefore, we separated polyclonally activated CD40L+ or CD40L- 
peripheral CD3+CD8+ T cells into the developmental stages naïve (N, 
CD45RA+CCR7+), effector (E, CD45RA+CCR7-), effector memory (EM, CD45RA-
CCR7-) and central memory (CM, CD45RA-CCR7+) prior to bisulphite 
sequencing. CD3+CD4+ T cells and CD3-CD19+ B cells were included as 
respective CD40L+ or CD40L- control. We observed demethylation at the 
promotor, both enhancers and the -8kb intragenic region in CD40L+CD4+ T cells, 
while all those regions except of the 5´-enhancer were methylated in CD40L- B 
cells. In CD8+ T cells, independent of their maturation level (N, EM, CM, E), the 
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methylation data exhibit a clear correlation between methylation status and 
CD40L expression ability at the promotor. In line with the observations from CD4+ 
T cells and B cells, the 5´-enhancer is also demethylated in a CD40L independent 
manner in CD8+ T cells (Figure 12). In contrast, the 3´-enhancer is only 
demethylated in CD4+ but not CD8+ T cells. One intragenic region at -8kb exhibit 
a diverse methylation status in CD40L+ versus CD40L- CD8+ N, EM and CM T 
cells similar to the promotor but however also CD40L- effector CD8+ T cells are 
demethylated in this area. The further candidates, the 4 extragenic regulatory 
elements and one intragenic candidate did not show a correlation with CD40L 
expression in the initial experiment and were excluded from further analyses. 
Altogether, DNA-methylation seem to regulate CD40L expression ability by 
different methylation solely at the promotor whereas the 5´- enhancer is 
continuously accessible and the 3´-enhancer is CD4+ but not CD8+ T cell specific. 
For the novel identified -8kb intragenic region an impact on CD40L expression 
ability is possible but would require another mechanism to silence CD40L in 
effector compared to CD40L- N, EM and CM CD8+ T cells. 
 
 
Figure 12: DNA methylation profile of peripheral cells. 
Naïve (CD45RA+CCR7+), effector (CD45RA+CCR7-), effector memory (CD45RA-CCR7-) and 
central memory (CD45RA-CCR7+) CD3+CD8+ T cells as well as CD3+CD4+ T cells and CD3-
CD19+ B cells were sorted from human PBMCs. After 6hrs polyclonal stimulation with 
PMA/Iono in the presence of αCD40, CD8+ T cells were separated into CD40L+ and CD40L- 
subsets. Following DNA isolation, bisulphite sequencing was performed. Methylation level 
shown as heat map with blue = full methylation, yellow = no methylation, white = no data 
available. n=2. 
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3.1.4  DNA demethylation of the CD40L promotor is activation independent 
Polyclonal activation that was required to identify the CD40L expressing T cells 
among N, CM, EM and E CD8+ T cells can alter DNA methylation pattern as rapid 
as 5 hours following stimulation (Kersh et al., 2006). In order to exclude that 
stimulation dependent changes caused the differences in the methylation pattern, 
we screened the CD8+ T cell compartment for markers that identifies CD40L 
expressing cells ex vivo.  
 
 
Figure 13: DNA methylation imprinting is stimulation independent.  
(A) Example gating strategy: CD8+ T cells were distinguished into CCR7+CD45RA+ naïve 
(N), CCR7-CD45RA+ effector (E) and CD45RA- memory cells consisting of CCR7+ central 
memory (CM) and CCR7- effector memory cells (EM). Within total CD45RA- memory cells, 
1-2% coexpress CCR6+ CCR4+. (B,C) CD40L expression of CCR6+CCR4+ memory CD8+ T 
cells compared to CCR6-CCR4- memory CD8+ T cells, CD8+ effector T cells and CD4+ T cells 
after polyclonal stimulation with PMA/Iono for indicated time. (B) CD40L mRNA analyzed by 
qPCR, (C) CD40L surface staining in the presence of αCD40 analyzed on a flow cytometer. 
(D) CD8+ T cells were enriched from human PBMCs by MACS and CD45RA-CCR6+CCR4+ 
CD8+ T cells sorted. One half was stimulated polyclonally with PMA/Iono for 6hrs and used 
with the unstimulated control for bisulphite sequencing.  
R E S U L T S  
 
42 
 
We found a CD45RA- memory CD8+ T cell fraction expressing the chemokine 
receptors CCR6 and CCR4 that homogenously expressed high levels of CD40L 
mRNA and protein upon stimulation (Figure 13A, B). The DNA methylation 
pattern of the regulatory regions of this subset was compared prior and after 
polyclonal activation. We observed no stimulation dependent demethylation but 
instead rather a slight increase in methylation for the promotor, the -8kb intragenic 
region and the 3´-enhancer while the 5´-enhancer retained its demethylated 
conformation. Therefore, we conclude that DNA demethylation of regulatory 
elements is an intrinsic and critical regulator of CD40L expression in CD8+ T cells, 
which is implemented in a stimulation independent manner (Figure 13C). 
 
3.2  The CD40L expression ability of T cells is implemented in 
the thymus  
3.2.1  Naïve CD40L expressing CD8+ T cells are true naïve cells 
The DNA methylation pattern can be altered by the inhibition of the de novo 
methylation after cell division or in an active process by TET enzymes (Smith and 
Meissner, 2013; Wu and Zhang, 2014). The clear difference between the CD40L+ 
and CD40L- naïve CD8+ T cells in DNA methylation pattern therefore raises the 
question whether the CD40L+ T cells are truly naïve cells or antigen experienced 
cells with a naïve phenotype. A fraction of memory cells, T memory stem cells 
(TSCM) and memory T cells with naïve phenotype (TMNP), can express the naïve 
cell markers CD45RA and CCR7 we used for our experiments (Gattinoni et al., 
2011; Pulko et al., 2016). Therefore, we wanted to exclude the possibility that 
naïve CD40L+ CD8+ T cells from our DNA methylation experiment had already 
encountered their cognate antigen. First, we controlled the gating strategy by co-
staining of CD45RA and CCR7 with CD95 and CD11a, markers that are shared 
by TSCM and TMNP cells. Only 2-3% of the CD8+ T cells in the CD45RA+CCR7+ 
compartment co-expressed CD95 and CD11a and therefore were lower in their 
frequency than CD40L+ CD8+ T cells in this compartment that acoount for around 
10% (Figure 14A). Furthermore, we assessed the number of T cell receptor 
excision circles (TRECs) in sorted CD45RA+CCR7+ naïve CD8+ T cells that were 
either CD40L+ or CD40L+ and compared it to respective CD45RA- memory CD8+ 
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T cells. T cell receptor excision circles are formed during TCR rearrangement of 
T cells in the thymus but are not duplicated during cell division and therefore dilute 
out with increasing cell division. As the TREC number was comparable among 
the two naïve subsets and hardly detectable in the memory cells (Figure 14B), 
we conclude that CD40L+ naïve CD8+ T cells are not antigen experienced cells 
that differentiated into the CD40L+ phenotype upon antigen encounter. Instead, 
CD40L+ naïve CD8+ T cells must have their DNA methylation pattern and CD40L 
expression ability imprinted at earlier stages of development. Moreover, the 
slightly reduced number of TRECs in naïve CD40L- cells might be caused by a 
relative higher frequency of TSCM or TMNP cells among them. 
 
 
Figure 14: Naïve CD40L+ CD8+ T cells are not antigen experienced. 
(A) CD8+ T cells were enriched from human PBMC by MACS and CD95 and CD11a 
expression on naïve CD45RA+CCR7+ versus memory CD45RA- CD8+ T cells assessed by 
flow cytometry. (B) Following stimulation with PMA/Iono in the presence of αCD40, CD40L+ 
and CD40L- naïve (CD45RA+CCR7+) and memory (CD45RA-) CD8+ T cells were sorted. 
DNA was isolated and TRECs quantified by qPCR. n = 4 
 
3.2.2  CD40L expression ability of CD8+ T cells is implemented in the thymus  
As already naïve CD8+ T cells could be distinguished into CD40L+ and CD40L- 
fractions by their DNA methylation pattern, the DNA demethylation imprinting 
probably takes place at an earlier time point in T cell development. Therefore, we 
assessed whether precursors of naïve cells in thymus are already able to express 
CD40L. T cell precursors wander from the bone marrow into the thymus. Here 
they undergo several developmental stages from DN1-4 over DP while 
rearranging their TCR. After positive selection validated TCR functionality and 
negative selection depleted strong autoreactive cells, the remaining cells mature 
into CD4+ or CD8+ SP cells that egress into the blood as naïve T cell (see 1.2.2). 
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Those developmental stages can be dissected by the expression of CD1a and 
CD3 in human thymocytes. CD1a is expressed from DN1 stage until successful 
TCR rearrangement occurred, positive and negative selection was passed and 
CD3 expression is induced at DP stage (Figure 15A) (Weerkamp et al., 2006). 
We observed that CD40L expression accompanies CD3 induction at DP stage 
and continues in CD4+ and CD8+ SP stage (Figure 15B). While almost all CD4+ 
SP thymocytes express CD40L upon stimulation, an average of 5% of CD8+ SP 
thymocytes are CD40L+ (Figure 15C, D). 
 
Figure 15: CD40L expression among human thymocytes.  
(A) Developmental stages in thymus from CD4-CD8-CD1a-CD3-DN (1) CD4-CD8-CD1a+CD3- 
early DP (2), CD4+CD8+CD1a+/lowCD3low/+ DP (3 and 4) to CD4+ or CD8+ CD1a-CD3+ SP (5) 
according to ex vivo CD1a and CD3 expression. (B) CD40L expression in different thymic 
developmental stages as shown in (A) stimulated 6hrs with SEB/TSST-1 in the presence of 
αCD40. (C) Example dot plot of CD40L frequencies in CD8+ and CD4+ SP thymocytes 
stimulated 6hrs with SEB/TSST-1 in the presence of αCD40. (D) Summarized frequencies of 
CD40L+ T cells among indicated CD1a- CD3+ CD4+ or CD8+ SP cells. Mean ± SEM. 
 
In murine thymus, T cell development stages can be dissected by the expression 
of CD3, CD24 and CD25. While CD25 is exclusively expressed in DN stage, 
CD24 expression declines with proceeding maturation of the T cells (Baldwin et 
al., 2005). Positive selection induces expression of CD3 in DP cells that now 
further mature to CD4+ or CD8+ SP cells. Co-staining of CD40L revealed 
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induction of CD40L expression at the DP to SP transition accompanied by CD3 
expression in line with our observations in human thymus (Figure 16A). At CD3+ 
SP stage, around 3-4% of murine CD8+ thymocytes were expressing CD40L 
(Figure 16B, C). Taken together in human and mouse the ability to express 
CD40L is implemented during DP stage in CD4+ and some CD8+ T cells.  
 
Figure 16: CD40L expression in murine thymocytes. 
(A) T cell developmental stages in murine thymus from CD25+CD24++ DN (1), CD25-CD24++ 
early DP (2), CD25-CD24+ DP (3), CD25-CD24low DP to SP transition to CD25-CD24- SP 
stage. (B) Expression of CD40L in CD3+CD24- CD8+ SP or CD4+ SP thymocytes after 
stimulation with PMA/Iono for 6hrs in the presence of BrefA. (C) Summarized frequencies of 
CD40L+ cells among CD4+ or CD8+ SP cells. Mean ± SEM. n=6. 
 
3.2.3  The DNA methylation pattern of the CD40LG locus is imprinted in the 
thymus 
In order to understand whether CD40L expression ability from DP stage onwards 
is reflected by subsequent changes in the DNA methylation, we assessed 
CD40LG locus methylation in the different stages of T cell development. DN, DP, 
CD4+ SP and CD8+ SP were separated into CD40L- or CD40L+ fractions after 
polyclonal stimulation and analyzed by bisulphite sequencing. Methylation 
analysis revealed that the detection of CD40L protein on the surface is 
accompanied by a subsequent demethylation of the CD40LG promotor beginning 
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with DP and established at SP stage (Figure 17). Moreover, the 5´-enhancer and 
the intragenic region became demethylated during thymic T cell maturation. The 
3’-enhancer displayed a beginning demethylation only in CD4+ SP T cells in line 
with data gathered from circulating T cells where demethylation was CD4+ T cell 
exclusive and complete (see Figure 12). Therefore, the ability to express CD40L 
by some CD8+ (and all CD4+) T cells is regulated by DNA methylation status of 
the CD40LG promotor which is implemented in the thymus. 
 
Figure 17: Demethylation of the CD40LG locus is imprinted in the thymus. 
Thymocytes were sorted into DN (CD1a+CD3-CD4-CD8-), DP (CD3intCD4+CD8+) and SP 
(CD3+CD4+ or CD3+CD8+) subsets and stimulated polyclonally with SEB/TSST-1 for 6hrs in 
the presence of αCD40. After separation of CD40L+ from CD40L- cells by sort, bisulphite 
sequencing was conducted. n=2. 
 
3.3  The CD40L expression stability 
3.3.1  Stability of CD40L expression correlates with the DNA methylation 
status  
Our data suggest an imprinting of CD40L expression ability during thymic 
development by DNA demethylation of regulatory elements of the CD40LG locus. 
However, previous work also revealed an induction of CD40L expression in naïve 
cells upon stimulation and cultivation in the presence of IL-12 resulting in CD40L+ 
CD8+ T cells with cytotoxic phenotype including co-expression of IFN- as well as 
lytic molecules (Stark et al., 2013). In order to understand the interplay of these 
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two mechanisms, we analyzed the stability of CD40L expression at different 
stages of T cell development in the presence and absence of cytokines, 
especially IL-12. To this purpose, isolated CD8+ SP thymocytes as well as naïve 
and memory CD8+ T cells were stimulated polyclonally to separate CD40L+ from 
CD40L- cells and cultivated in the presence of cytokines. In all three cell types, 
only a minority of sorted CD40L- cells expressed CD40L after cultivation, which 
most likely results from incomplete sort due to a delayed CD40L expression 
kinetic during activation. Among the sorted CD40L+ cells from CD8+ SP 
thymocytes as well as naïve CD8+ T cells, CD40L expression turned out to be 
unstable. In line with data gathered from naïve cells (Stark et al., 2013), IL-2 
stabilizes the ability to express CD40L also in CD8+ SP thymocytes (Figure 18A). 
Furthermore, thymocyte survival was dependent on the presence of either IL-2 
or IL-7. However, IL-12 did not contribute to CD40L stability or resulted in 
increased CD40L+ frequencies in thymocytes. In naïve cells, IL-12 but neither IL-
7/IL-15 nor IL-18 as control were capable to induce CD40L expression in a 
mechanism that is independent of the thymic imprint but required proliferation as 
the effect is observable earliest from day 2 on (Figure 18B). In contrast, memory 
CD8+ T cells have stable CD40L expression that is unaffected by the presence 
of cytokines (Figure 18C). This increasing stability of CD40L expression in CD8+ 
T cells from thymic SP over naïve to memory stages paralleles the progressing 
DNA demethylation at regulatory elements of the CD40LG locus during T cell 
maturation (see Figures 12, 17). Altogether, thymic implementation and IL-12 
dependent imprint in proliferating cells compose two separate processes of 
CD40L induction in CD8+ T cells. 
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Figure 18: Stability of CD40L expression in different developmental stages of CD8+ T 
cells. 
Sorted CD3+CD8+ SP thymocytes (A) as well as CCR7+CD45RA+ naïve (B) and CD45RA- 
memory (C) PBMC derived CD8+ T cells were stimulated with plate bound αCD3 and αCD28 
for 6hrs in the presence of αCD40 and sorted into CD40L+ and CD40L- cells. Separated cells 
were further stimulated with CD3/CD28 for 40hrs and cultivated in the presence of 
indicated cytokines for 7 days in total. Frequencies of CD40L expressing cells were assessed 
by restimulation with PMA/Iono for 6hrs in the presence of CD40 and subsequent flow 
cytometric analysis. n = 3. Mean ± SEM. 
 
3.3.2  Stability of CD40L expression is regulated by CD28 mediated co-
stimulation 
As stability of CD40L was reported to be dependent on the presence and duration 
of CD28 signaling and strong TCR signaling during activation of naïve cells 
increased the frequency of CD40L+ CD8+ T cells (McDyer et al., 2002; Snyder et 
al., 2007; Stark et al., 2013), we assessed the effect of different concentrations 
of αCD28 and αCD3 in the initial T cell activation on CD40L stability in 7 day 
cultures (Figure 19). 
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Figure 19: High levels of αCD28 increase while high levels of αCD3 impair the stability 
of CD40L expression.  
Sorted naïve CCR7+CD45RA+ CD8+ T cells were stimulated 2 days with plate bound αCD3 
and αCD28 in indicated concentrations. After 5 more days of cultivation, cells were 
restimulated with PMA/Iono for 6hrs in the presence of αCD40 and CD40L expression 
assessed on a flow cytometer. n = 2. Mean ± SEM. 
 
While stimulation with high concentrations of CD28 significantly increased the 
stability of CD40L expression, CD3 contributed to this effect only in 
concentrations between 0.1-1 µg/ml. Higher concentrations exhibited a negative 
effect on CD40L expression. Altogether, CD40L can be imprinted in the thymus 
or recruited from naïve CD8+ T cells in the presence of IL-12. The stability of 
CD40L expression in imprinted cells depends on the strength of CD28 co-
stimulation during T cell activation and the presence of IL-2 during proliferation 
(also see Stark et at., 2013). 
 
3.4  CD40L imprinting in the thymus is accompanied by higher 
TCR avidity during positive selection 
 
3.4.1  Thymic CD40L+ CD8+ T cells are selected in a MHCI dependent manner 
Next, we aimed to assess which mechanism is responsible for the implementation 
of CD40L expression in some but not all CD8+ T cells in the thymus. As CD40L 
expression is accompanied by CD3 expression - a marker of successful positive 
and negative selection in the thymus - positive T cell selection might play a role 
in CD40L imprinting. CD4+ T cells that are all capable of expressing CD40L are 
selected by MHCII presented peptides. Therefore, we first wanted to assess 
whether CD40L imprint in CD8+ T cells occurs by classic MHCI dependent 
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peptide recognition or instead by a MHCII dependent mechanism. Therefore, we 
analyzed the CD40L expression in CD8+ SP thymocytes of MHCI and MHCII 
knockout (KO) mice. MHCI knockout led to an impaired maturation of CD8+ SP 
cells accompanied with increased frequencies of CD4+ SP T cells while MHCII 
KO caused the opposite effect. However, in MHCII KO mice CD40L expression 
on CD8+ SP T cells was comparable to WT mice, excluding the possibility of a 
MHCII dependent selection of those cells (Figure 20A). The absence of CD40L 
expression on the few CD8+ T cells that were detectable in the spleen of MHCI 
KO further support the concept of a MHCI dependent selection mechanism 
(Figure 20B). However, it cannot be completely ruled out that this effect is caused 
by the impaired CD8+ SP T cell development in MHCI knockout.  
 
Figure 20: CD40L+ CD8+ T cells are selected in a MHCII independent but MHCI 
dependent manner. 
(A) Murine thymocytes or (B) splenocytes from WT, MHCI KO and MHCII KO mice were 
stimulated polyclonally with PMA/Iono for 6hrs in the presence of BrefA. Intracellular CD40L 
and IFN- expression was analyzed by flow cytometry.  
 
3.4.2  CD40L+ CD8+ T cells express higher levels of the TCR avidity markers  
The mechanism of positive selection of CD4+ and CD8+ T cells in thymus not only 
differs in the utilized MHC, these cells are selected to, but also in the signaling 
intensity that they experience during selection (Liu and Bosselut, 2004) (see 
1.2.3). Detection of MHCII presented peptides results into a longer binding of the 
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DP cell to the APC and subsequent stronger TCR signaling than detection of 
MHCI presented peptides. This long, strong signaling during MHCII dependent 
selection implements CD4+ T cell fate which is paralleled by the ability to express 
CD40L. We therefore hypothesized that CD40L imprinting in CD8+ T cells might 
be caused by a stronger TCR signaling during selection compared to those CD8+ 
T cells that are unable to express CD40L. CD5 is a marker that is expressed 
relative to the TCR avidity the cell is selected to (Azzam et al., 1998; Moran et 
al., 2011). Therefore, we assessed CD5 expression of polyclonally activated 
murine CD8+ SP thymocytes (Figure 21). CD40L+ CD8+ SP thymocytes 
expressed higher CD5 levels compared to CD40L- CD8+ SP cells suggesting a 
stronger TCR signal in CD40L+ T cells during selection. 
 
Figure 21: Murine CD40L+ CD8+ SP T cells express higher levels of the TCR avidity 
marker CD5. (A, B) Thymocytes from B6 mice were stimulated 6h with PMA/Iono, stained 
intracellularly and subsequently analyzed on a flow cytometer. (A) Exemplary CD40L and 
CD5 staining of unstimulated and stimulated total alive thymocytes. (B) Geometric mean of 
CD5 in CD40L+ or CD40L- T cells pregated to CD3+CD8+ or CD3+CD4+ SP thymocytes 
respectively. One representative experiment out of 2 shown. ntotal = 10. Mean ± SEM. 
Student`s t-test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
 
However, CD4+ SP T cells also differ in CD5 MFI among CD40L+ and CD40L- 
cells. Therefore, we utilized different murine models with transgenic MHC class I 
restricted TCR to exclude a possible bias in CD5 readout caused by different 
responsiveness/viability during polyclonal activation. H-Y and OT-I mouse strains 
differ in their CD5 expression and reactivity (Fulton et al., 2015; Kieper et al., 
2004). H-Y mice express a TCR against a Y chromosome encoded male antigen 
resulting in T cells that have imprinted low CD5 levels from positive selection and 
are depleted during negative selection in male but not female mice. In contrast, 
OT-I cells express an ovalbumin specific TCR and high levels of CD5 indicating 
they were selected with strong avidity to some unknown self-peptide (Clarke et 
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al., 2000). We first validated the CD5 expression levels in female H-Y and OT-I 
mice that were bred on RAG2KO background to exclude endogenous TCR and 
compared to WT mice (Figure 22A). Subsequent polyclonal stimulation of 
splenocytes revealed large differences in CD40L expression with almost absent 
CD40L expression in H-Y mice followed by 5-10% in WT mice and frequencies 
close to 60% in OT-I mice (Figure 22B). These results suggest, that the TCR 
affinity during MHC class I dependent T cell selection in the thymus regulates 
CD40L expression. 
 
Figure 22: High TCR affinity promotes maturation of CD40L+ CD8+ T cells. 
(A) CD5 expression of CD3+CD8+ splenocytes of WT, female H-Y RAG2KO and OT-I RAG2KO 
mice was measured ex vivo on a flow cytometer. (B) Splenocytes were stimulated 
polyclonally with PMA/Iono in the presence of BrefA. Intracellular CD40L expression of 
CD3+CD8+ T cells was measured. Mean ± SEM. Data of 2 independent experiments. 
 
In order to validate whether also human CD40L+ CD8+ T cells were selected with 
high affinity to self-peptides during positive selection, we assessed the gene 
expression of human CD40L+ versus CD40L- CD8+ SP thymocytes. In line with 
the previous mouse data, gene expression of CD5 and a second TCR avidity 
marker NUR77 was higher in CD40L+ cells compared to CD40L- CD8+ SP cells 
(Figure 23A). Furthermore, sort of the 6-7% of naïve CD8+ T cells with lowest and 
highest CD5 MFI respectively resulted in twice as much CD40L+ frequencies 
within the CD5high fraction after polyclonal activation (Figure 23B, C). Altogether, 
the ability to express CD40L seem to be imprinted by strong detection of self-
peptides during maturation in the thymus in human and mouse. 
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Figure 23: Human CD40L+ CD8+ T cells express higher levels of CD5 and NUR77.  
(A) Human thymocytes were stimulated polyclonally with SEB/TSST-1 in the presence of 
aCD40 and CD40L for 6hrs. CD1a- CD3+ CD4- CD8+ SP cells were sorted into CD40L+ and 
CD40L- fraction and used for RNA-sequencing. Mean ± SEM. (B) Representative histogram 
of CD5low and CD5high gating among naïve CD45RA+CCR7+CD11a-CD95- CD8+ T cells. (C) 
CD5low and CD5high cells were sorted from naïve CD8+ and CD4+ T cells, stimulated with plate 
bound αCD3/αCD28 in the presence of αCD40 and CD40L antibody for 12hrs and CD40L 
frequencies assessed by flow cytometry. Data represents 2 independent experiments. 
Student`s t-test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
 
3.4.3  CD40L expression is implemented during positive and not negative 
selection 
We observed CD40L implementation in T cells from DP stage on beginning with 
the co-expression of CD3 which is upregulated upon positive and negative 
selection. Among CD4+ T cells that egress from positive selection, those CD5high 
cells that strongly bind to AIRE dependent autoantigens presented in the thymic 
medulla undergo agonistic selection and become FoxP3+ regulatory T cells (Ono 
and Tanaka, 2016). In order to distinguish whether implementation of CD40L in 
CD8+ T cells already occurs during positive- or similar to Tregs during negative 
selection, we utilized the markers CD69 and CCR7 (Figure 24A). The early T cell 
stages in the thymic cortex lack CD69 and CCR7 expression. TCR signaling 
during positive selection results in CD69 upregulation followed by CCR7 
expression. CCR7 is crucial for migration from the cortex into the medulla where 
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the cells undergo negative selection as CD69+CCR7high cells. Mature cells 
downregulate CD69 and egress from thymus into blood (Takada et al., 2015; 
Van Laethem et al., 2013). All CD1a-CD3+CD40L+ cells were CD69+ but just 
partially CCR7+ suggesting an implementation during positive selection in the 
cortex. However, this approach is challenged by the necessity of a stimulation for 
CD40L detection that also induces CD69 upregulation. Therefore, we additionally 
compared the expression of CCR7 and CD25 of CD40L+ T cells with FoxP3+ 
Tregs as those must have passed negative selection in the medulla for successful 
FoxP3 implementation (Figure 24B). As a large fraction of CD40L+ T cells are 
CCR7-CD25- in contrast to FoxP3+ Tregs, induction of CD40L took place prior to 
migration into the medulla. In summary, we conclude that CD40L expression is 
implemented during positive but not negative selection.  
 
Figure 24: CD40L expression begins with CD69 upregulation in thymic cortex  
Human thymocytes were stimulated polyclonally with SEB/TSST-1 in the presence of aCD40 
and CD40L for 6hrs. (A) CD69 and CCR7 expression in total thymocytes (grey) compared to 
CD1a-CD3+ CD40L- (blue) or CD40L+ (red) T cells. (B) FoxP3 and CD40L expression in 
polyclonally activated CD3+ thymocytes (left). CCR7 and CD25 in CD40L+ or FoxP3+ cells 
(right). 
 
3.5  CD40L+ CD8+ T cells develop into unique memory T cells 
3.5.1  The CD8+ memory T cell compartment consists of different Tc subsets 
We demonstrated that the ability to express CD40L in CD8+ T cells is 
implemented during high affine detection of self-antigens during positive 
selection. Next, we wanted to assess whether this affects the further fate of the 
cells. The cytokine milieu during the activation of naïve T cells and the 
subsequent proliferation regulates the induction of diverse transcription factors 
resulting in the formation of distinct memory subsets with unique functions and 
cytokine profiles (Sallusto, 2016). Peripheral CD4+ memory T cells can be 
distinguished ex vivo into Th1, Th2, Th17, Th17+1 and Th22 subsets based on 
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the expression patterns of the chemokine receptors CCR4, CCR6, CCR10 and 
CXCR3 (Acosta-Rodriguez et al., 2007; Bonecchi et al., 1998; Sallusto et al., 
1998; Trifari et al., 2009). We saw before that the chemokine receptors CCR4 
and CCR6 identify a CD40L expressing memory CD8+ T cell fraction (see Figure 
13). This raised the question, whether the concept of chemokine receptor 
expression can be transferred to CD8+ memory T cells and how CD40L 
expression is distributed within these subsets. We could show that the CD8+ 
memory T cell compartment contains subsets with CD4+ T cell matching 
chemokine receptor expression pattern: Tc1 (CCR6-CXCR3+CCR4-), Tc2 (CCR6-
CXCR3-CCR4+), Tc17+1 (CCR6+CXCR3+CCR4-), Tc17 (CCR6+CXCR3-
CCR4+CCR10-) and Tc22 (CCR6+CXCR3-CCR4+CCR10+) (S. Warth, PhD 
thesis; Loyal et al., submitted). While the different CD4+ T cell subsets account 
relatively equally for around 10-20% of memory CD4+ T cells respectively, the 
Tc1 fraction dominates in CD8+ memory with 60% followed by Tc17+1 and Tc2 
with around 10% and Tc17 and Tc22 with around 1% (S. Warth, PhD thesis; Loyal 
et al. submitted). Interestingly, all cells assigned to the subsets Tc2, Tc17, and 
Tc22 express CD40L (Figure 25). In contrast, only a minor fraction of Tc1 and 
Tc17+1 cells co-expressed CD40L together with IFN- suggesting an IL-12 
dependent imprint (S. Warth, PhD Thesis; Stark et al., 2013). This data suggests, 
naïve CD40L+ CD8+ T cells preferentially differentiate into cells with chemokine 
receptor expression patterns that would assign them to Tc2, Tc17 and Tc22 cell 
subsets. 
 
Figure 25: Tc2, Tc17 and Tc22 memory CD8+ T cells express CD40L similar to CD4+ T 
cells. 
Proportion of CD40L expression among sorted and polyclonally activated Tc and Th cell 
subsets (n=6). Data adapted and extended from S.Warth. Mean  SEM. 
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However, we first wanted to assess in depth the reliability of the CD8+ memory 
compartment separation by their chemokine receptor expression pattern. We 
validated whether these subsets secrete according cytokines as known from the 
different CD4+ Th subsets by performing a multiplex cytokine array from the 
supernatants of sorted and polyclonally stimulated memory CD8+ and CD4+ T cell 
subsets. In line with published data (Maggi et al., 1994; Salgame et al., 1991), 
only Tc/Th1 and Tc/Th17+1 subsets produced IFN- and the Tc/Th2 subsets 
were the main IL-4 and IL-13 producers (Figure 26A). However, Tc17 and Tc22 
cells also responded with rapid IL-13 secretion within the first 24hrs and even 
produced IL-4 after 72hrs of stimulation. The Tc/Th17 and Tc/Th17+1 cells 
secreted IL-17 that is also produced by Tc/h22 cells at the later timepoint (Figure 
26A). IL-22 and the anti-inflammatory cytokine IL-10 were only detected after 
prolonged stimulation in Tc/h17 and Tc/h22 cells (Figure 26B). TNF-α was 
produced relatively equally by all cell types and GM-CSF dominately by Tc2 and 
Th17+1 cells. None of the cell subsets produced IL-1b, IL-8 or IL-12p70 (not 
shown). 
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Figure 26: Cytokine secretion profile of the memory CD8+ T cell subsets Tc1, Tc2, 
Tc17+1, Tc 17 and Tc22 compared to their respective CD4+ T cell subsets.  
CD45RA- CD8+ (black) or CD4+ (grey) memory T cell subsets Tc1/Th1 (CCR6-
CXCR3+CCR4-), Tc2/Th2 (CCR6-CXCR3-CCR4+), Tc17+1/Th17+1 (CCR6+CXCR3+CCR4-), 
Tc17/Th17 (CCR6+CXCR3-CCR4+CCR10-) and Tc22/Th22 (CCR6+CXCR3-CCR4+CCR10+) 
were sorted and stimulated at 1x104 Cells/100ul for 24hrs (A) or 72hrs (B) with CD3/CD28. 
The supernatant was utilized for multiplex cytokine ELISA. n = 10/3 (Tc/Th, 24hrs), n = 4/4 
(Tc/Th, 72hrs). Mean ± SEM.  
 
3.5.2  RNA-Sequencing revealed similarities in the gene expression of CD4+ 
and CD8+ memory T cell subsets 
In order to understand whether there is a common gene expression signature in 
the CD40L expressing memory CD8+ T cell subsets Tc2, Tc17 and Tc22 and how 
these subsets are related to the CD40L+ CD4+ T cell subsets, we performed RNA-
sequencing of highly purified CD4+ and analogous CD8+ memory T cell subsets. 
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Strikingly, unsupervised clustering of normalized data separated the CD8+ 
subsets Tc1 and Tc17+1 from Tc2, Tc17 and Tc22 and placed the latter ones in 
the proximity of the CD4+ T cell subsets (Figure 27). 
 
Figure 27: Top 1000 differentially expressed genes among CD8+ and CD4+ memory T 
cell subsets.  
RNA was isolated from sorted memory CD45RO+CD8+ or CD4+ T cell subsets Tc1/Th1, 
Tc2/Th2, Tc17+1/Th17+1, Tc17/Th17 and Tc22/Th22 and used for RNA-sequencing. 
Heatmap displays top 1000 most variable expressed genes. n = 3. 
 
The high analogy of distinct CD4+ and corresponding CD8+ T cell subsets with 
respect to their chemokine receptor profiles and cytokine secretion patterns 
moreover suggested that similar molecular differentiation mechanisms might act 
for both CD4+ and CD8+ T cell subtypes. In order to avoid general differences 
between CD4+ and CD8+ T cells as well as between donors cover common 
signatures among the Tc and Th subsets, we performed a batch compensation. 
This resulted in clusters of distinct CD8+ T cell subsets with their corresponding 
CD4+ T cell counterpart. The clustering pattern furthermore revealed a similarity 
between Tc1/Th1 and Tc1/Th17+1 cell subsets, while Tc2/Th2, Tc17/Th17 and 
Tc22/Th22 cell subsets established a separate cluster (Figure 28).  
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Figure 28: Top 1000 differentially expressed genes among CD8+ and CD4+ memory T 
cell subsets after batch compensation.  
Heatmap of top 1000 most variable expressed genes after normalization and batch 
compensation of RNA-seq analyses. n = 3. 
 
A principal component analysis (PCA) of all differentially expressed genes of the 
compensated data set confirmed a strong correlation of the respective Tc and Th 
cell subsets across all donors with a particular similarity of Tc17/Th17 and 
Tc22/Th22 cells (Figure 29A). The similarity between distinct CD4+ T cell subsets 
and corresponding CD8+ T cell subsets was further supported by the analysis of 
key transcription factors controlling differentiation and maintenance of distinct 
functional memory T cells (Coghill et al., 2011). While the expression of TBX21 
and RORC was restricted to IFN-- and IL-17A-secreting subsets in both CD4+ 
and CD8+ T-cell subsets, GATA3 gene expression and protein was detectable in 
Th2, Tc2 but also in Tc17 and Tc22 cell subsets (Figure 29B, C). In contrast, all 
CD4+ Th subsets as well as Tc2, Tc17 and Tc22 CD8+ T cells express AHR that 
is strongest in Th/c17, and Th/c22 subsets respectively (Figure 29B, C). We 
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therefore conclude that similar molecular mechanisms are responsible for 
memory T-cell subset differentiation and/or maintenance in both CD4+ and CD8+ 
T-cell subsets, respectively. Additionally, Tc2, Tc17 and Tc22 cells also display 
strong overall similarities with CD4+ T cells in their gene expression including the 
expression of the classical helper molecule CD40L suggesting they might 
represent a subset of CD8+ T cells with helper-type features. 
 
Figure 29: CD8+ and CD4+ memory T cell subsets resemble in TF gene expression.  
(A) Principal component analysis (PCA) of all protein coding expressed genes (B) 
Normalized, log2 transformed expression of indicated transcription factors among Th and Tc 
subsets. Mean ± SEM. (C) Intracellular staining for TF of indicated Tc subsets. 
 
3.5.3  CD8+ memory T cells subdivide into cytotoxic and non-cytotoxic 
subsets 
In order to assess in depth what differs the single subsets from each other we 
performed a gene ontology overrepresentation analysis (ORA) of the differentially 
expressed genes, which revealed an enrichment of signatures associated with 
the gene clusters “immune response”, “cell activation”, “communication” and 
“trafficking”. These mainly comprised of immunomodulatory and cytotoxicity 
markers as well as cytokine and chemokine receptors. For example, the 
chemokine receptor CCR5 was expressed by Tc1 and Tc17+1 CD8+ cells 
together with the cytotoxicity markers Granzymes A, B, H, K, M, Granulysin, 
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Perforin as well as other markers such as LAG3, CRTAM and NKG7 (Figure 29) 
(Boles et al., 2005; Hidalgo et al., 2008; Kohlmeier et al., 2008). However, Tc1 
and Tc17+1 cells could be clearly distinguished from each other by cytokine 
receptors as IL-17RE, IL-18R and IL-23R as well as Tc1 markers ITGAM, CD38 
and TIGIT. 
   
Fig.30: Tc1 and Tc17+1 differ from Tc2, Tc17 and Tc22 in the expression of genes 
associated with cytotoxicity, immunomodulation, activation and migration. 
Heatmap representation of normalized, log2 transformed RNA-seq expression values of 
selected genes enriched in gene ontology ORA analysis. 
 
In contrast, Tc2, Tc17 and Tc22 lacked expression of cytotoxicity-associated 
genes. Instead, they expressed the Th2 CD4+ T cell related gene PTGDR2 
(CRTH2) (Figure 30) (Fanis et al., 2007; Nagata et al., 1999). Together with 
CCR8, the receptors used for cell subset identification (CCR4, CCR10) and the 
cytokine receptors (IL-6R, IL-9R), Tc2, Tc17 and Tc22 cell subsets displayed 
many characteristics of skin migratory T cells, where non-cytotoxic subsets of 
CD8+ T cells have been demonstrated to exert a barrier protection function (Fu 
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et al., 2016; Huber et al., 2009; Schaerli et al., 2004; Tubo et al., 2011). Notably 
Tc2, Tc17 and Tc22 subsets also expressed more genes associated with 
immunomodulatory function of the B7-CD28 and TNFRSF superfamilies than the 
cytotoxic subsets Tc1 and Tc17+1 (Chen and Flies, 2013).  
Expression of cytotoxicity related genes was one of the most prominent 
signatures that distinguished Tc1 and Tc17+1 from Tc2, Tc17 and Tc22 cell 
subsets. The mRNA of Perforin and Granzyme B was shown to be pre-stored in 
cytotoxic cells but only translated into protein upon T cell activation (Pipkin et al., 
2010). Therefore, we assessed the protein levels of the lytic molecules Perforin 
and Granzyme B in the different T cell subsets ex vivo. Among Tc1 cells, 40% 
co-expressed Perforin and Granzyme B protein but almost none of the Tc17+1 
cells (Figure 31A). Furthermore, we found a small fraction Th1 CD4+ T cells 
expressed cytolytic molecules which are the characteristic markers for cytotoxic 
CD4+ T cells (Mattoo et al., 2016). Next, we aimed to analyze whether there is a 
common mechanism that regulates the helper (CD40L expression) versus 
cytotoxic (expression of lytic molecules) phenotype in both CD4+ and CD8+ T 
cells and whether this mechanism might affect the ability to express CD40L, too. 
We could show that compared to non-cytotoxic, classical helper CD4+ T cells 
cytotoxic CD4+ T cells completely lack CD40L expression (Figure 31B). Cytotoxic 
CD4+ T cells acquire their cytotoxic phenotype in a Runx3-dependent manner 
and Runx3 overexpression was shown to impair CD40L expression (Mucida et 
al., 2013). Therefore, we assessed Runx3 levels in sorted CD4+ and CD8+ T-cell 
subsets. Cytotoxic CD8+ memory (Tc1/Tc1+1), cytotoxic CD4+ and effector CD8+ 
T cells expressed comparable levels of Runx3, whereas helper-type memory 
CD8+ T cells (Tc2, Tc17, Tc22) possessed as little Runx3 as helper CD4+ memory 
T cells (Figure 31C). However, naïve CD40L+ and CD40L- CD8+ T cells did not 
differ in their expression of Runx3 or the Runx3 repressor ThPOK (Figure 31D). 
Therefore, among memory T cells both CD4+ and CD8+ fractions can be 
subdivided into different Th/Tc subsets according their cytokine profile as well as 
into cytotoxic and non-cytotoxic, helper-type subsets that differ in their CD40L 
and Runx3 expression. 
R E S U L T S  
 
63 
 
Figure 31:  Cytotoxic CD4+ and CD8+ memory T cells do not express CD40L but Runx3. 
(A) PBMCs were stained ex vivo for Granzyme B and Perforin and measured by flow 
cytometry. Gated on respective Tc/Th subset according to their chemokine receptor pattern.  
(B) Granzyme B and CD40L co-expression of sorted, polyclonally activated helper memory 
CD4+ (CD45RA-CD28+CD57-) and cytotoxic memory CD4+ (CD45RA-CD28-CD57+) T cells 
compared to unstimulated control. (C) Effector CD8+ (CD45RA+CCR7-), cytotoxic CD8+ 
memory (CD45RA-CXCR3+CCR4-), cytotoxic CD4+ (CD45RA-CD28-CD57+), helper CD8+ 
memory (CD45RA-CXCR3+CCR4-) and helper CD4+ (CD45RA-CD28+CD57-) T cells were 
sorted and intracellular Runx3 expression assessed. Numbers in plot indicate the MFI. (D) 
MACS enriched CD4+ and CD8+ T cells were polyclonally activated and sorted into CD40L- 
and CD40L+ naïve subsets. Runx3 and ThPOK were assessed intracellularly. 
 
3.5.4  SLAMF7 and IL-6R distinguish cytotoxic from non-cytotoxic T cells 
In order to identify further markers that can distinguish cytotoxic from helper-type 
T-cell subsets we screened for genes that were differentially expressed in the 
cytotoxic T-cell populations (Tc1, Tc17+1) compared to all other non-cytotoxic Tc 
and Th subsets. We could identify 28 genes that were more weakly and 22 genes 
that were more strongly expressed among the cytotoxic T cell subsets (Figure 
32A). Strikingly, the two cell surface molecules SLAMF7 and IL-6R displayed a 
converse expression pattern among all lymphocytes (Figure 32B). In 
concordance, all CD4+ as well as CD8+ Tc2, Tc17 and Tc22 helper T-cell subsets 
but not the cytotoxic Tc1 and Tc17+1 cell subsets expressed high levels of IL-6R 
(Figure 32C). Opposing expression patterns were observed for SLAMF7 that was 
only expressed by the cytotoxic Tc1 and Tc1+17 CD8+ memory T-cell subsets 
and all Granzyme B and/or Perforin expressing CD8+ T cells (Figure 32 D). Naive 
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CD8+ and CD4+ T cells lacked SLAMF7 but expressed IL-6R, whereas cytotoxic 
CD8+ effector T cells expressed the highest levels of SLAMF7 (Figure 32E). 
SLAMF7 was co-expressed on all CD8+ T cells expressing Granzyme B, Perforin 
and/or IFN- after in vitro activation (Figure 32F). Moreover, SLAMF7 is 
detectable among Granzyme B+ Perforin+ cytotoxic CD4+ T cells (Figure 32F). 
Since all further cytotoxic subsets among lymphocytes, the CD56 expressing NK, 
NKT and ILC1 cells were SLAMF7+IL-6R- (Figure 32G), SLAMF7 represents a 
highly suitable marker to assess the cytotoxic potential of lymphocytes while IL-
6R represents the non-cytotoxic fraction. 
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Figure 32: SLAMF7 and IL-6R expression distinguishes cytotoxic memory CD8+ and 
CD4+ T cells from non-cytotoxic cells. 
(A) Heatmaps of normalized and scaled genes distinguishing cytotoxic (Tc1 and Tc17+1) 
and non-cytotoxic CD8+ and CD4+ T cell subsets (Tc2, Tc17, Tc22, Th1, Th2, Th17, Th17+1, 
Th22). (B) Representative dot plot of IL-6R and SLAMF7 expression among lymphocytes. 
(C, D) Flow cytometric stainings indicating frequency and MFI of of IL-6R (C) and SLAMF7 
(D) among CD45RA-CD4+ and CD8+ T cell subsets. (E) MFI of of IL-6R and SLAMF7 of 
CD45RA+CCR7+ naïve CD4+ and CD8+ T cells and CD45RA+CCR7- effector CD8+ T cells 
(F) Flow cytometric co-stainings of SLAMF7 with Granzyme B, Perforin and IFN- after 6hrs 
of polyclonal activation in the presence of BrefA, gated on CD8+ T cells or CD4+ T cells. (G) 
Representatitve dot plot of SLAMF7 and IL-6R coexpression with CD56 among lymphocytes. 
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3.5.5  CD40L+ memory CD8+ T cell subsets possess a unique TCR repertoire  
Previous studies have suggested a relative plasticity in cytokine production and 
lineage transcription factor expression among differentiated CD4+ memory T-cell 
subsets (Kunicki et al., 2017; O’Shea and Paul, 2010). Becattini et al. furthermore 
demonstrated heterogeneous differentiation of pathogen-specific CD4+ T cells 
into distinct CD4+ helper T cell sister clones (Becattini et al., 2015). However our 
CD40L expression pattern suggests a preferential differentiation of CD40L+ naive 
CD8+ T cells into Tc2, Tc17 and Tc22 memory CD8+ T cells. To assess a potential 
corporate contribution of the different CD8+ T-cell subsets to specific immune 
responses, we performed TCRβ-chain deep sequencing of isolated Tc subsets. 
The relative numbers of clonotypes were smaller in Tc17 and Tc22 cells 
compared to Tc1, Tc2 and Tc17+1 with a few clones dominating their repertoire 
(Figure 33A, B). While less than 0.6% of the clones are present in frequencies 
above 1%, they accounted for 60% (Tc17) and 90% (Tc22) of the reads (Figure 
33C, D). The oligoclonal repertoire in Tc17 and Tc22 cells with a few dominating 
clones suggests a highly specialized response in contrast to the rather polyclonal 
Tc1, Tc17+1 and Tc2 cells. 
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Figure 33: Some clones are enriched among Tc17 and especially Tc22 cells. 
Tc1, Tc2, Tc17, Tc17+1 and Tc22 were sorted from human PBMC and analyzed by TCR-
sequencing. (A) Number of clones found in different subsets. Mean ± SEM. (B) Number of 
clonotypes and their frequency of reads of one representative donor. (C) Number of 
clonotypes present at frequencies >1% in the total clonotype pool. (D) Cumulative frequency 
of all clonotypes present at frequencies >1%.  
 
Next, we asked whether the oligoclonality of Tc17 and Tc22 cells is caused 
by a limited selection of TCRs, which would suggest a detection of invariant 
MHCs (MHC-Ib). We therefore assessed the TCR-V usage of the different 
donors among naïve and the different Tc subsets (Figure 34). The V families 
varied among donors as well as among Tc17 and Tc22 indicating they detect 
diverse antigen:MHCs combinations. However, Tc17+1 cells displayed a strong 
enrichment for TCR-V chains of the V6 family and therefore might recognize 
antigens presented in a MHC-Ib dependent manner. 
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Figure 34: TCR-V familiy usage verifies TCR polyclonality among Tc17 and Tc22 T 
cells.  
Pie charts of the percentage of the different V family contributions to the total TCR repertoire 
of naïve CD8+ T cells and memory Tc subsets. 
 
The clone repertoire revealed that most clones overlap within the two cytotoxic 
subsets Tc1 and Tc17+1 and within the three non-cytotoxic subsets Tc2, Tc17 
and Tc22 (Figure 35A). In total 5-10% of the clonotypes and around 50% of the 
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reads were shared by the cytotoxic and by the helper-type subsets, respectively 
(Figure 35B, C). Given the small overlap between those two groups in their 
shared clonotypes and shared reads, cytotoxic and helper-type CD8+ T cells 
detect distinct epitopes and were most likely involved in diverse antigenic 
responses. However, within such response heterogeneous differentiation or 
plasticity allows the differentiation of either Tc1 or Tc17+1 cells and accordingly 
either Tc2, Tc17 or Tc22 cells.  
 
Figure 35: The clone repertoire overlaps among the cytotoxic and among the non-
cytotoxic CD8+ memory T cell subsets.  
(A) Venn Diagram of an example donor visualizes number clonotypes shared among 
different Tc subsets. (B) Summary of clonotype numbers shared among different Tc subsets 
from all donors. (C) Summary of reads shared among different Tc subsets from all donors. 
 
3.5.6  Naïve CD40L+ and CD40L- CD8+ T cells have distinct TCR repertoires  
The implementation of CD40L expression in some CD8+ T cells in the thymus 
and the striking different clone repertoire of memory CD40L+ CD8+ T cells 
suggest that the imprinting in the thymus dictates the fate of the CD8+ T cell in 
the periphery. Given this assumption, thymic imprinted CD40L+ CD8+ SP T cells 
shape the naïve CD40L+ repertoire, which preferentially differentiate into Tc2, 
Tc17 or Tc22 T cell upon activation. First, we therefore compared the clone 
R E S U L T S  
 
70 
repertoire of naïve CD40L+ and naïve CD40L- CD8+ T cells. After thymic egress, 
estimated 50-100 sister clones circulate in the blood (Gonçalves et al., 2017). As 
10% of the naïve cells in blood express CD40L, either 1 clone out of 10 sister 
clones randomly gain CD40L expression ability (same clone, different fates) or 
every 10th clone experiences a CD40L imprinting signal and shares the CD40L 
expression ability with its sister clones (one clone, one fate) (Figure 36). 
 
Fig. 36: Hypotheses for CD40L+ CD8+ T cells development.  
Same clone, different fates: during positive selection and proliferation in the thymus a small 
fraction out of a population of sister clones gains the ability to express CD40L. One clone, 
one fate: some clones receive a different signal during selection and differentiate into CD40L+ 
cells. 
 
Due to physiological and technical limitations, approximately 1/20th of the total 
naïve CD8+ T cell TCR repertoire can be assessed reducing the possibility of 
overlaps in the repertoire of two naïve populations. To understand the 
significance of the overlap among CD40L+ and CD40L- naïve CD8+ T cells, we 
calculated the frequency of clones that were found in numbers higher than one 
clone in the complete repertoire consisting of CD40L+ and CD40L- cells. In 
average 37% of the clones were found multiple times in the total pool as well as 
among CD40L+ or CD40L- naïve CD8+ T cells alone (Figure 37A). In a next step, 
we assessed the overlap of CD40L+ and CD40L- clones in the overall pool and a 
singleton free pool resulting in maximum frequencies around 0.1-1% (Figure 
37B). The difference between the two values suggests diverse clone repertoires 
of CD40L+ and CD40L- naïve CD8+ T cells with the small overlap rather derived 
from incomplete stimulation of some CD40L+ clones that therefore falsely were 
assigned as CD40L- clones. As 99% of the TCRβ chains were shown to be unique 
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(Gonçalves et al., 2017), the overlap could also be generated by random overlaps 
in TCRβ sequences that in the end belong to different TCRs with diverse α-
chains. Therefore, TCR sequencing demonstrated that naïve CD40L+ and 
CD40L- CD8+ T cells are two subsets with diverse TCR repertoires. 
  
Figure 37: Overlaps in the clonotypes of naïve CD40L+ and CD40L- CD8+ T cells. 
Naïve CD45RA+CCR7+ CD8+ T cells were sorted and stimulated polyclonally with PMA/Iono 
for 6hrs in presence of αCD40. CD40L+ and CD40L- cells were sorted and subsequently used 
for TCR-sequencing. (A) Frequencies of clones present more than once in the clone 
repertoire. (B) Overlap of clonotypes present >1x among CD40L+ and CD40L- naïve CD8+ T 
cells. Mean ± SEM.  
 
3.5.7  CD40L expressing memory T cells are recruited from CD40L+ naïve T 
cells 
When a naïve clone encounters its antigen, the cell undergos massive 
proliferation and contributes to the immune response. After pathogen/antigen 
clearance some of the initial clones remain as memory cells. In murine models, 
not all naïve sister clones that were released from thymus contribute to a specific 
immune response, therefore a clonal overlap between the naïve and the memory 
pool should be detectable by TCR sequencing (Quinn et al., 2016). In order to 
proof whether the clones in the human memory Tc subsets are recruited from the 
naïve CD40L+ or CD40L- pool we compared the clonal overlap of the Tc subsets 
with naïve CD40L+ and CD40L- cells. However, the clone overlap ranged from 
0.01 to maximum 2%, suggesting that in humans either the majority of naïve 
sister clones is recruited to the immune response and/or the part of cells from the 
whole repertoire in human body we analyzed here was too limited for a reliable 
readout. However, the non-significant tendencies suggested that Tc1 cells are 
rather recruited from the CD40L- whereas Tc2, Tc17 and Tc22 cells are rather 
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derived from the CD40L+ naïve CD8+ T cell repertoire (Figure 38). For Tc17+1 
cells the picture remained inconclusive. 
 
Figure 38: The overlap in clone repertoire among naïve CD40L+ and CD40L- cells with 
memory Tc1, Tc2, Tc17, Tc17+1 and Tc22 cells. 
Numbers of clonotypes from the respective naïve and Tc subset were summarized and the 
numbers of clones found in naïve as well as Tc subset plotted as frequency of total clone 
numbers. 
 
3.6  Role of CD40L+ CD8+ T cells in immunity 
 
3.6.1  CD40L expression in systemic lupus erythematosus 
We demonstrated that naïve CD40L+ and CD40L- CD8+ T cells give rise to distinct 
sets of memory T cell subsets and the high affinity of CD40L+ CD8+ T cells against 
self during positive selection suggests a potential role of those memory Tc2, Tc17 
and Tc22 cells in the development of autoimmunity. In psoriasis, a chronic 
inflammatory skin disease, CD8+ T cells infiltrating the dermis and epidermis and 
characterized by IL-17A and IL-22 production have been implicated in the 
pathogenesis (Hijnen et al., 2013; Res et al., 2010; Zheng et al., 2007). Moreover, 
the frequencies of IL-22 producing, peripheral CD8+ T cells were increased in 
psoriasis patients (Luan et al., 2014). In line with that, we observed an increase 
of circulatory non-cytotoxic Tc2, Tc17 and Tc22 CD8+ T cells accompanied by 
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respective changes in cytokine secretion patterns in psoriasis but not atopic 
dermatitis (S. Warth, PhD Thesis; Loyal et al., submitted).  
As increased CD40L levels have been reported in SLE patients (Desai-
Mehta et al., 1996; Mak and Kow, 2014), we also analyzed the circulatory T cell 
compartment from SLE patients in comparison to healthy controls. As reported, 
we found deregulated cytokine production and increased levels of CD40L not 
only in CD8+ and CD4+ memory cells (Figure 39) but also in naïve and CD4-CD8- 
T cell subsets (not shown) (Ohl and Tenbrock, 2011). However, the changes in 
cytokine levels were not significant and did not correlate with the disease severity 
measured by SLEDAI score.  
 
Figure 39: Cytokine secretion of CD4+ and CD8+ memory T cells in SLE patients.  
Human PBMC from healthy donors or SLE patients were stimulated 6hrs with PMA/Iono in 
the presence of BrefA and cytokine as well as CD40L expression was assessed 
intracellularly. Pregated on CD3+CD45RA- memory CD8+ or CD4+ T cells. Mean. nhealthy = 13, 
npatients= 26. 
 
Furthermore, the changes in cytokine expression were not reflected by changes 
in the Tc and Th subset composition. While the frequencies of Tc1 cells remained 
unaltered, Tc17+1 cells were decreased in all SLE patients. In contrast, 
frequencies of Tc17 and Tc22 cells tendentially increased in patients with a 
SLEDAI score >8, whereas Th subsets did not exhibit any significant difference 
(Figure 40). However, SLE is also associated with aberrant DNA methylation 
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patterns, which are already imprinted in naïve stage (Absher et al., 2013). 
Therefore, our data suggests, that the observed changes in cytokine secretion 
are not caused by deregulated T cell differentiation but rather by deregulated 
DNA methylation. 
 
Figure 40: Frequencies of Tc and Th subsets in SLE patients.  
Frequencies of Tc/Th subsets in healthy and SLE patients were assessed ex vivo on a flow 
cytometer. Mean. nhealthy = 22 , npatients (SLEDAI<8) = 23, npatients (SLEDAI>8) = 5. Mann-Whitney t-
test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
 
3.6.2  Role of CD40L+CD8+ T cell subsets in barriers 
Non-lymphoid tissues such as skin, lung and gut possess specialized, resident 
form of memory T cells that express CD69 and/or CD103 (Schenkel and 
Masopust, 2014). They can be formed upon priming of T cells in skin 
accompanied by the induction of a circulatory fraction providing immunity at 
adjacent barriers or alternatively recruited from the circulatory T cell pool upon 
inflammation (Gaide et al., 2015; Jameson and Masopust, 2018; Jiang et al., 
2012). Among those CD8+ T cells located in dermal and epidermal layers of skin 
a large fraction exhibits a non-cytotoxic phenotype and characteristically lack 
CD49a expression (Cheuk et al., 2017; Purwar et al., 2011). Since helper-type 
CD8+ T cells lack cytotoxicity, express various markers of skin migration (see 
Figure 30) and we observed increased frequencies of circulatory Tc2, Tc17 and 
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Tc22 cells in patients with active psoriasis (S. Warth, PhD Thesis; Loyal et al., 
submitted), the non-cytotoxic CD8+ T cell subsets Tc2, Tc17 and Tc22 might be 
circulatory variants of skin resident cells (McCully et al., 2012, 2018). Comparison 
of the Tc-subset gene signatures with published signatures of skin derived dermal 
CD103+ and CD103-, epidermal CD103+CD49a+ and CD103+CD49a- TRM and as 
well as blood derived CLA+ and CLA- TEM cells as controls (Cheuk et al., 2017) 
placed helper-type CD8+ T cells in the proximity of the dermal cells (Figure 41A). 
Tc1 and Tc17+1 cells are heterogenous regarding their CLA expression and 
additionally contain not only TEM but also TCM cells (Figure 41B) resulting into 
adjacent but separate clusters of blood derived CLA+/CLA- and Tc1/Tc17+1 cell 
subsets that were both distinct from skin derived cell populations. 
The Tc2, Tc17, Tc22 and Th2 subsets that were enriched in psoriasis 
patients share the production of IL-13 (see Figure 26). IL-13 activates CCL26 
secretion by keratinocytes (Kagami et al., 2005), which results in a positive 
feedback loop of CCR4 expressing T cells and in parallel antagonizes the 
migration of cytotoxic CXCR3+ cells (Nakayama et al., 2010; Purwar et al., 2006). 
We found high levels of CCL26 in keratinocytes treated with supernatants of 
stimulated Tc2, Tc17, Tc22 but not of stimulated Tc1 or Tc17+1 subsets (Figure 
41C). In contrast, helper-type CD8+ T cells did not affect the levels of CXCL11 
expression, which is a ligand for CXCR3 expressed by cytotoxic memory CD8+ T 
cell subsets. These results support the hypothesis that circulatory human non-
cytotoxic CD8+ T cell subsets might migrate into the skin and may play a so far 
unrecognized role in the amplification of skin immunity.  
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Figure 41: Skin associated signature of non-cytotoxic CD8+ T cell subsets. 
(A) PCA of CD8+ memory T cell subsets and CLA+/CLA- blood derived CD8+ TEM, 
CD103+/CD103- dermis derived, CD49a+/CD49a- epidermis derived CD8+ T cells as 
described in (Cheuk et al., 2017). (B) CLA expression among Tc and Th subsets (n = 4). (C) 
Relative expression of CCL26 and CXCL11 by keratinocytes stimulated with supernatants 
derived from sorted and activated Tc cell subsets. Mean  SEM. Student`s t-test. *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001 relative to medium as control. 
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4.  DISCUSSION 
CD40L, a central costimulatory receptor to provide help, is transiently expressed 
upon activation in all CD4+ and some CD8+ T cells. Previous work showed that 
around 10% of naïve CD8+ T cells are capable to express CD40L whereas the 
frequency increases to around 30% in the memory compartment (Frentsch et al., 
2013). This increase suggests an implementation of CD40L expression during 
differentiation, which could be partially linked to IL-12 dependent induction in the 
proliferation phase upon antigen encounter (Stark et al., 2013). The origin of 
CD40L expressing CD8+ T cells with “naïve” phenotype however remained 
unclear. We demonstrated that CD40L expression requires absent DNA 
methylation at the CD40LG promotor in CD4+ and CD8+ T cells, which is 
implemented in the thymus. The ability of CD8+ T cells to express CD40L is 
induced by high affinity detection of self-peptidess during positive selection in 
human and mouse. While subdivision of thymic CD4+ T cells into classical CD4+ 
T cells and natural regulatory T cells is widely accepted, our data proves for the 
first time that thymic CD8+ T cells are also heterogeneous. Moreover, thymus 
derived CD40L+ CD8+ T cells differ from CD40L- CD8+ T cells in their further 
development. They give rise to non-cytotoxic memory cells with defined cytokine 
secretion profiles of Tc2, Tc17 or Tc22 T cells while CD40L- CD8+ T cells 
differentiate into classical IFN-+ cells with a cytotoxic capacity. The CD40L+ 
“helper-type” CD8+ memory T cell subsets Tc2, Tc17 and Tc22 resemble CD4+ T 
cells in their gene expression and display a skin migratory phenotype. CD8+ T 
cells with helper-type cytokine profiles have been reported in allergy and various 
autoinflammatory diseases. Therefore, thymus derived helper-type CD8+ T cells 
might represent a unique force in cellular immunity requiring a re-evaluation of 
CD8+ T cell capabilities and functions in human health and disease. 
 
4.1  TCR dependent induction of CD40L expression  
Reports based on CD4+ T cell analyses indicate that TCR dependent CD40L 
induction is dependent on NFAT and NF-κB signaling. Utilizing highly specific 
chemical blockage during ex vivo stimulation of enriched T cells we observed that 
the induction of CD40L expression is comparably dependent on NFAT but not 
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NF-κB signaling in CD4+ and CD8+ T cells (Figure 10). However, the observation 
of NF-κB dependent activation of CD40L based on a proteasome inhibitor 
mediated blockage of IκB degradation, which also affects NFAT (Srahna et al., 
2001) and binding of NF-κB to the CD40L locus was shown in cell lines but not 
for primary cells (Schubert et al., 2002). Therefore, we conclude that NFAT is the 
central regulator of CD40L expression induction in both CD4+ and CD8+ T cells, 
while NF-κB is abdicable in situations with sufficient TCR stimuli.  
 
4.2  Regulation of CD40L gene accessibility 
Another regulatory mechanism of gene expression is to modify the usage and the 
accessibility of gene regulatory elements. We first assessed whether there are 
other regulatory elements in CD8+ T cells than those described for CD4+ T cells 
by an extensive in silico analysis including evolutionary conservation (human-
mouse homology), TF binding sites, DNase I hypersensitive sites and CpG 
sequences within a stretch of +/- 100kb from CD40LG gene (Figure 11). Since in 
diseases with deregulated CD40L expression in CD4+ T cells were related to 
changes in DNA methylation (Lian et al., 2012; Liao et al., 2012; Lu et al., 2007), 
we assessed the DNA methylation pattern of the known and novel identified 
candidates to understand a) the location of potential regulatory elements and b) 
the role of DNA methylation in CD40L expression. DNA methylation analysis of 
naïve, effector and memory CD8+ T cells revealed a strict correlation between 
absent DNA methylation and CD40L expression ability at the CD40L promotor 
region but not at other regions (Figure 12). At the 5´-enhancer the methylation 
pattern displayed an open DNA formation independent of CD40L expression 
ability. CD4+ T cells possess 2 DNAse I hypersensitive sites bound by NFAT and 
GATA3 in this upstream enhancer and these sites were not found in CD8+ T cells 
(Brunner et al., 2008).  Therefore, it is possible that these sites contribute to the 
differences in CD40L expression of CD4+ and CD8+ T cells. Moreover, the 3´-
enhancer, containing two NF-κB binding sites, was exclusively demethylated in 
CD4+ but not CD8+ T cells. Since we demonstrated, that NF-κB is negligible for 
CD40L induction upon proper TCR stimulation, this enhancer might rather 
contribute to CD40L expression/stability in CD4+ T cells under suboptimal 
conditions. Altogether, the ability to express CD40L is highly dependent on the 
D I S C U S S I O N  
79 
DNA methylation status at the CD40LG promotor in CD4+ and CD8+ T cells. While 
the 5´-enhancer might contribute to the CD40L expression in both cell types, the 
3´-enhancer is not accessible in CD8+ T cells.  
 
4.3  Mechanism of CD40L implementation in the thymus 
The absent DNA methylation at the CD40LG promotor of naïve CD40L+ but not 
CD40L- CD8+ T cells might result from a falsely assignment of the naïve status to 
cells that have encountered their cognate antigen yet or from demethylation 
earlier in T cell development. By the exclusion of memory T cells expressing the 
naïve cell markers CCR7 and CD45RA (TSCM/TMNP) as well as TREC analysis, 
we demonstrated the true naïve status of naïve CD40L expressing CD8+ T cells 
(Figure 14). Therefore, we assessed CD40L expression in the earlier 
developmental stages in the thymus. CD40L staining of activated thymocytes 
revealed CD40L gene expression from DP stage accompanied by CD3 co-
expression – a marker of sufficient TCR dependent T cell selection. In SP stage, 
around 3-5% of thymic CD8+ T cells expressed CD40L in human and mouse 
(Figures 15, 16). Correspondingly, bisulphite sequencing demonstrated absent 
DNA methylation at CD40LG promotor in DP as well as CD4+ and CD8+ SP 
CD40L+ thymocytes (Figure 17). Based on these results we conclude that CD40L 
expression is implemented in all CD4+ and some CD8+ T cells during thymic 
development at the transition to CD3+DP T cells. 
Dissection of the developmental stages in human and mouse thymus 
narrowed down CD40L expression implementation to the CD3+CD4+CD8low DP 
stage, a stage at which positive and negative selection as well as CD4 versus 
CD8 lineage decision has just taken place (Figures 15, 16) (Brugnera et al., 2000; 
Liu and Bosselut, 2004; Park et al., 2010). The major regulator of CD4+ versus 
CD8+ T cell decision is the length of the TCR signal during positive selection, 
which is dependent on the MHC and the TCR avidity to the presented peptide. 
While MHCI specific CD8+ T cells are selected with a weaker and shorter 
stimulus, CD4+ T cells, that are all expressing CD40L, are selected to a stronger 
stimulus in a MHCII dependent manner (Liu and Bosselut, 2004). With murine 
MHCI and MHCII knockout models, we could determine that positive selection of 
CD40L+ CD8+ T cells in the thymus is not dependent on the presence of MHCII 
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but requires the presence of MHCI (Figure 20). Accordingly, we found higher 
levels of CD5 and NUR77, markers of TCR stimulation strength during positive 
selection, in CD4+ T cells than CD8+ T cells. However, CD40L+ CD8+ T cells 
displayed higher levels of CD5 and NUR77 than CD40L- CD8+ T cells in human 
and mouse (Figures 21, 23). Correspondingly, transgenic mouse models with 
different CD5 expressions, expressed according levels of CD40L (Fulton et al., 
2015; Kieper et al., 2004). H-Y mice on RAG2-/- background (to exclude any 
endogenous TCR expression) had low CD5 expression and almost absent 
CD40L whereas OT-1 mice on RAG2-/- expressed high levels of CD5 and the 
majority of CD8+ T cells were CD40L+ (Figure 22).  
Among CD4+ T cells, the CD5high fraction develop into Tregs during 
negative selection in the medulla or become depleted (Ono and Tanaka, 2016). 
We utilized CCR7, a receptor necessary for migration from the cortex to the 
medulla, to identify whether positive selection in the cortex or negative selection 
in the medulla implements CD40L expression in the CD5high CD8+ T cells (Takada 
et al., 2015; Van Laethem et al., 2013). As CD40L is detectable prior to CCR7 
upregulation, T cells must have gained their ability to express CD40L during 
positive selection (Figure 24). Interestingly, the frequencies of thymus derived 
natural CD25+FoxP3+CD4+Tregs among CD4+ T cells and CD40L+CD8+ among 
CD8+ T cells are comparable with around 3-5% in thymic SP stage and around 
10% among naïve PBMC derived T cells and therefore might reflect the 
thresholds of high affinity selected T cells generated by T cell maturation and 
selection in the thymus (Moran et al., 2011).  
The intensity of TCR stimulus during positive selection not only regulates 
CD5 and NUR77 expression intensity but also influences the susceptibility of the 
pre-mature T cell to cytokine mediated signaling. A strong stimulus activates a 
CD4 lineage transcription factor ThPOK whereas weak signaling allows the 
induction of CD8 lineage transcription factor Runx3 by cytokines (Egawa and 
Littman, 2008; Muroi et al., 2008; Park et al., 2010; Wang et al., 2008). These 
two transcription factors ThPOK and Runx3 were associated with CD40L 
expression in several experimental setups. Lack of Runx3 expression or 
overexpression of ThPOK led to a moderate CD40L expression in cytotoxic CD8+ 
T cells (Shan et al., 2017; Tsuchiya et al., 2016). Furthermore, binding of Runx3 
to the CD40LG locus adjacent to the downstream enhancer was observed in 
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mouse (GSE50130, Lotem et al., 2013), suggesting a possible direct regulation 
of CD40L expression by Runx3. High affinity selection of CD8+ T cells therefore 
might open a window in the lineage transcription factor network that induces a 
CD4+ cell like DNA demethylation of CD40L locus together with CD8+ lineage 
decision. Despite CD40L+ memory CD8+ T cells expressed reduced levels of 
Runx3, no clear difference was observed in naïve and thymic SP CD8+ T cell 
stages (Figure 31). However, repression of CD40L in the majority of CD8+ T cells 
not only rely on DNA but also histone methylation, which can be repressed by 
ThPOK utilizing CXXC5 (Tsuchiya et al., 2016). Therefore, further epigenetic 
analyses are needed to possibly link high affinity selection with DNA 
demethylation at the CD40L locus in CD8+ T cells.  
 
4.4  Stability of CD40L expression 
When we separated CD40L+ and CD40L- CD8+ T cells ex vivo and cultivated 
them with or without cytokines, we could observe that CD40L- cells stably lack 
CD40L expression in thymic SP CD8+, naïve CD8+ as well as memory CD8+ T 
cells suggesting that the central CD40L implementation mechanism is the DNA 
demethylation during positive selection in the thymus (Figure 18). One exception 
is the cytokine IL-12 which is capable to implement CD40L expression in 
proliferating CD40L- naive cells resulting into cytotoxic, IFN- producing CD40L+ 
CD8+ T cells. We could previously show that the IL-12 dependent induction of 
CD40L occurs in a STAT4 dependent manner, which binds to the CD40L 
promotor (Stark et al., 2013). As the DNA methylation pattern in TEM and TCM cells 
(see Figure 12) does not distinguish between the thymus imprinted and the IL-12 
imprinted CD40L+ cells, and the frequencies of IL-12 imprinted cells in peripheral 
blood are higher than those of the thymus imprinted cells, we conclude that IL-12 
treatment induces CD40L gene expression by mediating CD40LG locus 
demethylation similar as during positive selection. This is in line with the 
observation, that the mechanism is strictly proliferation dependent suggesting 
STAT4 inhibits DNA remethylation after cell division by inducing DNA 
hyperacetylation of the loci it is bound to (Yu et al., 2007).  
While CD40L expression in CD4+ T cells is stable beginning with the 
implementation in the thymus, CD40L+ CD8+ T cells exhibit unstable CD40L 
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expression in thymocytes with increasing stability over naïve to memory cells. 
This difference in stability is reflected by the progress of DNA demethylation in 
CD8+ T cells (Figures 12, 17). Besides, CD4+ but not CD8+ T cells have a 
demethylated downstream enhancer containing NF-κB binding sites (Schubert et 
al., 2002). By transfection of primary CD4+ T cells with luciferase reporter gene 
constructs containing either the promotor alone or together with the enhancer, 
Schubert et al. measured higher luciferase activity upon polyclonal activation 
when the enhancer was present. In striking contrast, we demonstrated that NF-
κB blockage did not affected CD40L expression levels neither in CD4+ nor in 
CD8+ T cells. However, transfected constructs are susceptible to unwanted side 
effects. Therefore, genomic manipulation would be necessary to verify the role of 
this enhancer. As CD4+ T cells exhibit an overall higher stability of CD40L 
expression from the earliest developmental stages on, this enhancer might 
contribute rather to CD40L expression stability than its overall expression levels. 
Moreover, the upstream enhancer contains a GATA3 element, which is 
demethylated beginning with thymic SP T cell stage in all T cells and remains 
demethylated until memory stage where thymic imprinted CD40L+ CD8+ T cells 
(Tc2, Tc17, Tc22) begin to express GATA3 (Figures 12, 17) (Brunner et al., 
2008). Since CD4+ T cells express GATA3 from thymic SP stage on, GATA3 
binding to the enhancer might also support CD40L expression stability. Finally, 
we observed that in congruence with previous reports from CD4+ T cells, strong 
CD28 signals during naïve cell activation have supportive effect onto CD40L 
stability of CD8+ T cells, too (Figure 19) (Johnson-Léger et al., 1998). This effect 
is probably regulated by the CD28 responsive element in the CD40L locus, which 
is bound by CD28 induced NFAT and NF-κB (Parra et al., 2001).  
 
4.5  The fate of thymic imprinted CD40L expressing CD8+ T cells 
We could show that the CD45RA- CD8+ memory compartment can be dissected 
homologous to CD4+ T helper cells into the subsets Tc1, Tc2, Tc17, Tc17+1 and 
Tc22 according to their expression of the chemokine receptors CCR6, CCR4, 
CCR10 and CXCR3 with unique cytokine expression profiles (Figure 26) (S. 
Warth, PhD Thesis; Acosta-Rodriguez et al., 2007; Bonecchi et al., 1998; Sallusto 
et al., 1998; Trifari et al., 2009). Tc1 and Tc17+1 possess a cytotoxic phenotype 
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and contain some CD40L+ CD8+ T cells that are all IFN- co-producing and 
therefore most likely generated by IL-12 dependent priming upon naïve T cell 
activation. In contrast, Tc2, Tc17 and Tc22 are all expressing CD40L but no 
cytotoxic effector molecules such as Perforin, Granzymes or IFN- (Figures 25, 
31). This raised the question whether thymic imprinted CD40L+ cells not only give 
rise to the naïve CD40L+ pool but also strongly affect the memory T cell fate. TCR 
sequencing showed that among naïve CD40L+ and CD40L- cells around 40% of 
the clones are present more than one time in the repertoire – however only 0.5% 
of the total clones overlap between these two groups. Consequently, CD40L+ 
naïve cells seem to represent a separate cell type that recognizes different 
epitopes than CD40L- cells (Figure 37). Strikingly, a similar separation could be 
observed with the TCR sequences of Tc1/Tc17+1 on one side and 
Tc2/Tc17/Tc22 on the other side (Figure 35). While the TCR seqences displayed 
a strong overlap among the Tc2, Tc17 and Tc22 and among the Tc1 and Tc17+1 
subsets, there was little overlap between these two groups. We compared the 
TCR overlap between the naïve and the memory subsets but found too little 
overall overlap for a statistically significant correlation whether CD40L+ memory 
cells (Tc2/17/22) derived from the CD40L+ and Tc1/Tc17 from CD40L- naïve pool 
respectively (Figure 38). Importantly, the readout from this strategy is limited by 
the potential different migration behavior of the Tc memory subsets as for 
example Tc2, Tc17 and Tc22 cells express markers pointing to a migration into 
skin and therefore large parts of their TCR repertoire would be missed by the 
analysis of blood derived, circulatory cells. Since it is additionally unknown how 
many of the naïve sister clones present at a defined time in the body are recruited 
into the memory response in humans and sequencing the whole TCR repertoire 
of a subject is practically not possible, we tried a bioinformatical approach. We 
utilized the GLIPH algorithm to assess the overlap of the TCR CDR3 sequences 
– the areas of epitope recognition which exhibit highest inter-TCR variation – with 
a hamming distance of 1 (Glanville et al., 2017). Unfortunately, in large datasets 
this approach results in clusters above 50% of the CDR3 sequences and 
therefore requires additional TCR and HLA information for a feasible output. 
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4.6  Phenotype of the CD40L expressing memory CD8+ T cells 
Cytokine secretion analysis demonstrated that the separation of CD8+ memory T 
cells into the subsets Tc1, Tc2, Tc17, Tc17+1 and Tc22 directly ex vivo utilizing 
chemokine receptors adopted from CD4+ T cells is highly reliable. These subsets 
secrete the expected pattern of the cytokines IFN-, IL-4, IL-17 and IL-22 upon 
polyclonal activation (Figure 26). Furthermore, removal of donor and CD4+ versus 
CD8+ related differences in the RNA-seq data by batch algorithmus led to 
clustering of each CD8+ Tc subset with its respective CD4+ Th subset (Figure 27). 
This extreme similarity underlines the findings of publications claiming that both 
cell types utilize the same differentiation mechanisms based on the transcription 
factors T-bet, GATA3, RORt and AHR (Figure 29) (Sallusto, 2016). 
Unsupervised clustering of the genes furthermore revealed a cluster consisting 
of the CD8+ T cell subsets Tc1 and Tc17+1 separated from the subsets Tc2, Tc17 
and Tc22. Instead, the latter ones clustered with the CD4+ T cell subsets Th1, 
Th2, Th17, Th17+1 and Th22. This difference is strongly based on the cytotoxic 
signature of Tc1/Tc17+1 including cytolytic molecules (Granzymes, Perforin) and 
marker associated with a cytotoxic phenotype such as CRTAM and LAG3 (Figure 
30). However, in contrast to Tc1 we did not observed any Granzyme B and 
Perforin protein in Tc17+1 ex vivo (Figure 31). While mRNA of lytic enzymes is 
prestored, translation requires cell activation (Pipkin et al., 2010). Therefore, 
circulating Tc17+1 cells either did not encounter their cognate antigen recently or 
their RORt expression actively repress the production of cytolytic molecules in a 
STAT3 dependent manner (Ciucci et al., 2017; Curtis et al., 2009).  
Based on the observation that cytotoxic signatures are implemented and 
maintained by Runx3 in CD8+ as well as in cytotoxic CD4+ T cells and the non-
cytotoxic Tc2, Tc17 and Tc22 cells CD8+ T cells express GATA3 instead, which 
counteracts cytolytic signatures (Figure 29) (Mucida et al., 2013; Pipkin et al., 
2010; Woolf et al., 2003; Xiong et al., 2013), we assessed Runx3 levels in multiple 
cytotoxic and non-cytotoxic subsets. We could demonstrate that all cytotoxic 
subsets express Runx3 while Tc2, Tc17, Tc22 CD8+ and helper CD4+ T cells 
lacked Runx3 expression. Moreover, cytotoxic CD4+ T cells express Runx3 and 
at the same time are incapable to express CD40L, which indicates that Runx3 
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might be a central regulator of cytotoxic signature versus CD40L expression. As 
Runx3 and ThPOK control CD4+ versus CD8+ T cell fate in the thymus, reduced 
Runx3 levels might have been implemented in the thymus and underlie the 
CD40L expression ability of the thymic imprinted CD40L+ CD8+ T cells. However, 
we did not observed differences between Runx3 and ThPOK expression in thymic 
or naïve CD40L+ and CD40L- CD8+ T cells (Figure 31). In concordance, it was 
just shown that Runx3 expression levels of memory cells are implemented upon 
TCR activation of naïve cells by remodeled genome access prior to the first cell 
division (Wang et al., 2018). Cytotoxic CD4+ T cells moreover have lost their 
ThPOK expression (Mucida et al., 2013). It has been shown that ThPOK induces 
CXXC5, which in turn prevents histone methylation and associated repression of 
the CD40LG locus. Therefore, the lack of CD40L expression in cytotoxic CD4+ T 
cells might be ThPOK dependent (Tsuchiya et al., 2016). However, CD40L 
expressing CD8+ T cells displayed repressed ThPOK in all developmental stages 
comparable to CD40L- CD8+ T cells (Figure 31). Additionally, a CD4-Cre 
ThPOKfl/fl mouse model that lacks ThPOK expression from DP stage on displayed 
a defective development of mature CD4+ T cells but still gave rise to CD40L+ 
CD8+ T cells (not shown). Nevertheless, it was shown that Runx3 knockdown as 
well as ThPOK overexpression are capable of inducing CD40L expression in 
CD8+ T cells (Shan et al., 2017; Tsuchiya et al., 2016). Therefore, Runx3 seems 
to be critical for the implementation of the cytotoxic phenotype in memory CD8+ 
T cell subsets but whether and how Runx3 and ThPOK contribute to the 
regulation of CD40L expression remains elusive. 
In order to further assess how cytotoxic versus non-cytotoxic/helper-type 
CD4+ as well as CD8+ T cells  differ from each other, we analyzed the most 
differentially expressed genes among the cytotoxic Tc1 and Tc17+1 compared to 
the non-cytotoxic Tc2/Tc17/Tc22 and CD4+ Th subsets. We could identify 
SLAMF7 and IL-6R as opposed expressed indicators of cytotoxic versus helper 
phenotype of T cells. SLAMF7 is an already well-known marker of NK and NKT 
cells (Boles and Mathew, 2001; Bouchon et al., 2001). However, together with IL-
6R it distinguishes not only the non-cytotoxic naïve and Tc2/17/22 populations 
from the classical cytotoxic Tc1/17+1 and effector CD8+ T cells but also cytotoxic 
CD4+ from their normal helper counterparts (Figure 32). SLAMF7 is co-expressed 
on all Granzyme B+ and Perforin+ cells as well as on all CD56+ cells that includes 
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NK and NKT but also cytotoxic type1 innate lymphoid cells (ILC1) (Spits et al., 
2016). Comte et al. just recently demonstrated that ligation of SLAMF7 increases 
cytotoxic degranulation and IFN- secretion capacity in NK but also CD8+ T cells 
(Comte et al., 2017). In contrast, classical IL-6R mediated IL-6 signaling is 
associated with anti-inflammatory processes (Schaper and Rose-John, 2015). It 
increases the expansion and maintenance of CD4+ T cells (Rochman et al., 2005) 
and prevents their conversion into FoxP3+ Tregs (Korn et al., 2008). Therefore, 
IL-6R expression on CD8+ T cells might counteract the implementation of a 
cytotoxic phenotype and contribute to cell survival instead. Altogether, our data 
demonstrates that SLAMF7 provides a novel marker of overall cytotoxicity among 
cells of the lymphoid lineage whereas IL-6R identifies non-cytotoxic cells among 
lymphocytes. 
The CD40L+ memory CD8+ T cell subsets Tc2, Tc17 and Tc22 share their 
non-cytotoxic phenotype and a CD4+ helper cell related gene expression 
signature but they differ in their cytokine secretion profile. The strong overlap 
between CD4+ and CD8+ memory T cell subsets in the usage of the central 
differentiation regulating transcription factors T-bet, GATA3, RORt and AHR 
suggests that similar stimulation/cytokine milieus underlie the priming. However, 
priming of naïve CD8+ T cells with CD4+ T cell based protocols worked very 
inefficiently with maximum 0.1% (Tc17), 0.7% (Tc22) and 10% (Tc2) of primed 
CD8+ expressing the respective dominant cytokine IL-17, IL-22 and IL-4 (Kondo 
et al., 2009; Liu et al., 2011; Vukmanovic-Stejic et al., 2000). Interestingly, these 
frequencies resemble the total frequencies of the subsets Tc17, Tc22 and Tc2 
found ex vivo in blood (S. Warth, PhD Thesis). Together with the almost exclusive 
TCR repertoire, this might provide a hint that naïve CD8+ CD40L+ and CD40L- 
cells have an intrinsic fate implemented. Alternatively, the used priming 
conditions might not reflect physiological conditions properly. CD4+ T cell priming 
has been shown to be dependent not only on the cytokine milieu but also on the 
strength and duration of the TCR stimulus, the stimulation dependent induction 
of cytokine receptor expression as well as the antigen dose and the type of APC 
that mediates the T cell activation (van Panhuys, 2016; Rothoeft et al., 2003). In 
CD8+ T cells such factors were hypothesized to affect the TCM versus TEM as well 
as TRM differentiation but not taken into account for Tc subset differentiation so 
far (Kaech and Cui, 2012; Maru et al., 2017). The expression of different homing 
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receptors among CD8+ Tc subsets e.g. the skin homing receptors CCR4, CCR8, 
CCR10 among the non-cytotoxic subsets furthermore support the assumption 
that diverse priming conditions and associated APCs/sites of activation underlie 
their emergence. It has already been demonstrated that skin related APCs differ 
from classical dendritic cells, which dominate the systemic cytotoxic responses 
to viruses and bacteria in blood, an aspect that is further discussed below 
(Kashem et al., 2017). 
The TCR repertoire of the memory CD8+ T cells inherited a striking 
observation. For CD4+ memory T cells it has been shown that the naïve cell 
preferentially differentiates into one specific Th subset based on the pathogen 
that is faced but can give rise to a small number of other Th subsets at the same 
time (Acosta-Rodriguez et al., 2007; Arlehamn et al., 2013). Such asymmetric 
cell division was also described for the Effector/TEM/TCM differentiation of CD8+ T 
cells (Buchholz et al., 2013; Chang et al., 2007; Gerlach et al., 2013; Plumlee et 
al., 2013; Stemberger et al., 2007). Our TCR sequencing data revealed that also 
among TEM and TCM CD8+ T cells the flexibility is restricted. A naïve T cells can 
develop into a cytotoxic subset with a certain flexibility whether it gains a Tc1 or 
a Tc17+1 phenotype or alternatively into a non-cytotoxic subset with flexibility 
limited to Tc2, Tc17 or Tc22 phenotypes (Figure 35). The little overlap among the 
cytotoxic and the non-cytotoxic, helper-like compartment in the TCR and in the 
priming strongly indicates different combinations of antigen epitopes/stimuli 
underlying their differentiation. These combinations at the same time have to 
meet the conditions to give rise to TCM as well as TEM phenotype since those were 
found among all Tc subsets with a tendency to TCM for non-cytotoxic subset (S. 
Warth, PhD Thesis).  
 
4.7  The role of CD40L expressing CD8+ T cells in immunity 
We found IL-12 induced, IFN- co-expressing CD40L+ CD8+ T cells in large 
frequencies in several models of viral and bacterial immune responses (Durlanik 
et al., 2016; Schulz et al., 2015). These cells are capable of activating APC in a 
CD40L dependent manner similar to CD4+ T cells (Frentsch et al., 2013). Just 
recently, Tay et al. could show that this activation of DC by CD40L+ CD8+ T cells 
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provides a positive feedback loop that boost their expansion in inflammatory 
responses (Tay et al., 2017). 
But what role do thymic imprinted CD40L+ CD8+ T cells play in the immune 
system? We demonstrated that these cells are selected with high affinity against 
self during positive selection, differ from their CD40L- counterparts in naïve state 
and almost exclusively develop into type Tc2, Tc17 and Tc22 memory T cells, 
which exhibit a non-cytotoxic, helper-like phenotype and a TCR repertoire diverse 
from the one of the cytotoxic subsets. There are a couple of explanatory models 
that might unravel the role of thymic imprinted CD40L+ CD8+ T cells: their 
responsiveness & survival, migration & localization as well as their function. 
 
4.7.1  Responsiveness and survival 
The high affinity selection in thymus and higher CD5 expression of CD40L+ CD8+ 
T cells can have multiple consequences on their functionality in the periphery. 
The TCR sensitivity of T cells to self-peptides in the thymus influences the naïve 
phenotype of the cells. In murine models, CD5high cells were more susceptible 
and consequently proliferated better in the presence of the cytokines IL-2, IL-7 
and IL-15 (Cho et al., 2010; Fulton et al., 2015; Palmer et al., 2011). Higher affinity 
to self furthermore correlated with a stronger binding to foreign antigens 
accompanied by enhanced reactivity of CD4+ and CD8+ T cells (Fulton et al., 
2015; Mandl et al., 2013). For CD4+ T cells it was shown that the higher 
responsiveness of CD5high cells is not TCR dependent but an intrinsic feature 
(Persaud et al., 2014). Accordingly, those TCR with highest affinity among CD8+ 
T cells could be activated directly by peptides without CD8 co-receptor binding to 
the TCR:MHCI complex, which is usually required for efficient antigen recognition 
and CTL priming (Holler and Kranz, 2003; Wooldridge et al., 2007).  
However, higher affinity to self is accompanied by a higher risk for 
unspecific and uncontrolled activation and consequent development of 
autoimmunity. So why and how does the immune system tolerate CD8+ T cells 
with high specificity to self in the periphery? There are several mechanisms of 
tolerance beyond the selection in thymus: induction of anergy, exclusion from 
areas of antigen presence/formation of immune privileged sites and repression 
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by Tregs. We could not find increased expression of anergy/senescence markers 
such as LAG-3, CD160, PD-1, TIM-3, KLRG-1 and CD57 in CD40L+ CD8+ T cells 
in thymus or periphery (not shown). Furthermore, type Tc2, Tc17 and Tc22 were 
reported to be located at almost every part of the body: skin, gut, lung and CNS 
(Cheuk et al., 2014; Song et al., 2018; Tang et al., 2012; Tzartos et al., 2008). 
Whether regulatory T cells prevent autoantigen specific responses of CD5high 
CD8+ T cells in the periphery needs to be assessed. However, CD40L+ CD8+ 
memory T cells - similar to iTregs - are capable of producing the anti-inflammatory 
cytokine IL-10 and therefore might limit the extent of their own responses (Figure 
26). Their lack of cytolytic effector functions moreover might provide a form of 
intrinsic protection mechanism that prevents aberrant cell destruction. 
Additionally, CD5 itself is capable of lowering the TCR activation threshold in 
periphery and even can keep cells unresponsive (Dalloul, 2009; Hawiger et al., 
2004). Off note, T cell survival and maintenance of responsiveness in the 
periphery requires tonic TCR signaling by continuous TCR-self-peptide-MHC 
interaction (Takada and Jameson, 2009), which further modulate the CD5 levels 
(Smith et al., 2001). Therefore, high CD5 levels in thymic emigrants may be not 
fixed throughout naïve and memory stages of T cells and consequently in post-
thymic stages other mechanisms are required to ensure that CD8+ T cells with a 
high affinity to self-peptides are only activated in controlled environments. 
Lastly, there is inconsistent knowledge about how the mechanisms of the 
positive and negative selection is shaping the TCR affinity repertoire. Klein et al. 
proposed that the majority of T cells are selected to private peptides generated 
by the thymusproteasome in a way they are only bound with low affinity by the 
TCRs resulting into an increase of T cells passing positive and negative selection. 
However, some T cells instead detect public peptides generated by the 
immuneproteasome that are also presented and bind them with a comparably 
higher affinity resulting in re-encounter of these public peptides during AIRE 
mediated negative selection and (if they are not eliminated) into clones with a 
better reactivability in periphery (Klein et al., 2014). This share of labor between 
the two types of proteasomes increases the total TCR pool of T cells egressing 
into circulation. However, absence of thymusproteasomes (all variants) – 
allowing only the processing and presentation of public peptides by 
immunoproteasomes – resulted in the absence of CD5high clones and altered the 
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TCR pool but did not diminish the overall diversity (Kincaid et al., 2016). 
Therefore, we would hypothesize that CD5 is implemented upon recognition of 
private peptides and those cells binding too strong to public peptides are depleted 
during AIRE dependent negative selection. Consequently, CD5high CD40L+ CD8+ 
T cells would only bind thoses peptides with high affinity that by chance strongly 
resemble those designed by the thymusproteasome and usually are not present 
in the periphery as other proteasome variants shape the peptide repertoire in 
peripheral APCs. Since the CD5high CD40L+ CD8+ T cell phenotype is already 
observable in the cortex, we could exclude the possibility, that similar to Tregs, 
CD8+ T cells with high TCR affinity to peripheral autoantigens were purposefully 
disarmed during negative selection by implementation of a phenotype that leads 
to CD40L expression and a selective development into non-cytotoxic memory T 
cells (Figure 24). 
 
4.7.2  Migration and localization 
With CCR4, CCR8, CCR10 and CLA, the CD40L+ memory CD8+ T cell subsets 
express multiple markers indicative of a skin homing capacity (Figure 30). While 
CCR8 expression is instructed in naïve cells by keratinocytes (Gaide et al., 2015; 
McCully et al., 2012), CCR4, CCR10 and CLA are induced upon antigen 
encounter presented by DC in skin draining lymph nodes (Campbell and Butcher, 
2002; Campbell et al., 1999, 2007). Interestingly, similar to the circulatory 
cytotoxic versus non-cytotoxic memory CD8+ T cell subsets, CCR8- and CCR8+ 
tissue resident memory CD8+ T cells from skin differ in their TCR repertoire 
(McCully et al., 2018). We could demonstrate that the gene expression signature 
of the circulatory, non-cytotoxic, CD40L+ memory cells strongly resembles that of 
CD8+ T cells isolated from skin (Figure 41). Together with the increased 
frequencies of circulating Tc2, Tc17 and Tc22 cells in psoriasis patients, the data 
gathered in this thesis indicate a role of CD40L+ helper-type memory CD8+ Tcells 
cells in skin immunity. In clinically healed psoriasis patients possess enriched 
frequencies of IL-17 producing CD103+ TRM were found in skin (Cheuk et al., 
2014). Therefore, circulatory helper-type CD8+ T cells might be derived from skin 
based immune responses and able to (re)populate remote areas of skin. We 
showed that helper-type CD8+ T cell derived IL-13 induced CCL26 secretion by 
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keratinocytes, which might result in a positive feedback loop (Figure 41) (Kagami 
et al., 2005). CCL26 was demonstrated to recruit CCR4 expressing T cells and 
in parallel antagonizes the migration of cytotoxic memory and effector CD8+ T 
cells (Nakayama et al., 2010; Purwar et al., 2006). Moreover, the chemokine 
CCL20 is secreted by keratinocytes in healthy skin to promote wound healing 
(Kennedy-Crispin et al., 2012). However, it is also a central player in psoriasis as 
it recruits pathogenesis driving DC and T cells that express the CCL20 receptor 
CCR6 into lesions (Getschman et al., 2017; Kim et al., 2014). CCL20 is strongly 
enriched in psoriatic lesions and correlates with the CCR4 expression (Loyal et 
al., submitted). Therefore, CCR4+ helper-type CD8+ T cells with their CCL20 
induction capacity may directly contribute to the pathogenesis of psoriasis.  
The activation and priming conditions of helper-type CD8+ T cells in skin 
however are still a challenge to answer. While keratinocytes function as barrier 
and are capable of recruiting cells into the epidermis, they are no efficient antigen 
presenters. Instead, the human skin possesses 3 major DC subsets: Langerhans 
cells (LC), CD14+ DC and CD1a+ DC. Langerhans cells are located in the 
epidermis, can efficiently cross-presentate (uptake, process and present 
extracellular) antigens and strongly induce IFN- secretion in CD8+ T cells. They 
are competent CTL primers, possibly mediated by their ability to secrete the 
cytokine IL-15, which evokes cytotoxicity of CD49a+ epidermal CD8+ T cells 
(Cheuk et al., 2017; Oh et al., 2004). In contrast, CD14+ and CD1c+ DCs are 
located in the dermis. CD1c+ DC possess Th1 and Th2 priming capability and 
readily migrate into lymphatic vessels, carrying antigens to lymph nodes (Angel 
et al., 2006). CD14+ DC polarize naïve CD4+ T cells into follicular helper T cells 
and induce the rise of low cytotoxic, IL-13 secreting CD8+ T cells (Klechevsky et 
al., 2008). Since non-cytotoxic memory CD8+ T cells share the expression of IL-
13 (Figure 26), CD14+ DC might preferentially interact with and prime CD40L+ 
CD8+ T cells. Interestingly, Langerhans cell-mediated priming in the presence of 
anti-CD8 blocking antibody give rise to IL-13+ CD8+ T cell at frequencies 
comparable to CD14+DC mediated priming. CD14+ DC express ILT2 and ILT4 
receptors that bind classical (HLA-A and HLA-B) and non-classical (HLA-G1, -E, 
and -F) MHC and antagonistically compete with the CD8 coreceptor for its MHC 
binding (Banchereau et al., 2012; Endo et al., 2008; Shiroishi et al., 2003). CD8 
coreceptor binding to MHCI is usually required to stabilize the MHC binding to 
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the TCR and augments the TCR sensitivity (Artyomov et al., 2010). This leaves 
two options: a) CD40L+ but not the CD40L- CD8+ T cells were activated even in 
the absence of CD8 binding due to their high affinity or bridged by the additional 
signal derived from CD40L:CD40 interaction or b) specialized APCs such as 
CD14+ DC that block CD8 binding to the TCR:MHC complex inherit features that 
allow them to mediate a potent activation of CD40L+ CD8+ T cells. As CD40L+ 
naïve cells possess a TCR repertoire diverse from CD40L- cells, it is possible that 
CD14+ DC present a unique peptide repertoire that is for example designed by a 
specialized proteasome and modified in a way that only TCR of CD5high cells can 
bind strong enough and consequently become properly activated. CD14+ DC 
moreover were shown to secrete the cytokines IL-10 and TGF-ß (Klechevsky et 
al., 2008). The presence of IL-10 enables also LC to prime non-cytotoxic CD8+ T 
cells whereas block of IL-10 in CD14+DC does not prevent it. As a prominent 
fraction of skin CD8+ T cells possess a non-cytotoxic phenotype (Cheuk et al., 
2017; McCully et al., 2018) they might play a protective role in skin e.g. in wound 
healing or tolerance of commensal bacteria. It was recently demonstrated that 
murine non-cytotoxic skin Tc17 cells were primed in response to commensal 
bacteria derived peptides (Linehan et al., 2018). Those display an 
immunomodulatory signature that overlaps with the gene expression in our 
human circulatory non-cytotoxic CD8+ T cells including the upregulation of 
TNFRSF4, TNFRSF11a, TNFRSF18, TNFSF11, ICOS and CTLA4 (Figure 30). 
The murine skin resident Tc17 cells detect peptides presented by the invariant 
MHCIb molecule H2M3 and positively affect wound healing processes. H2M3 
presents peptides that contain an N-formyl-Methionine (fMet) sequence, which is 
a protein translation initiation signal in bacteria and of a small group of 
mitochondrial proteins (Fischer Lindahl et al., 1997). The distinct TCR repertoire 
of helper-type cells compared to cytotoxic cells may therefore result from antigen 
recognition presented by a so far unidentified human homolog of murine H2M3 
MHCIb. As the V-sequences of the TCR are also responsible for the binding of 
invariant types of MHCs display a high variance in helper-type CD8+ memory T 
cells, the searched invariant MHC has to display a broad V-usage similar to the 
Qa-1 homolog HLA-E (Figure 34). Moreover, our data generated from the MHCI 
KO model verified that the priming of CD40L+ CD8+ T cells is dependent on the 
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presence of -microglobulin which is a component of MHCI but also of invariant 
MHCs (Figure 20). 
 
4.7.3  Function 
a) Providing help when CD4+ T cells are limited/ MHCI dependent manner: 
Another hint regarding the role of CD40L+ CD8+ T cells in immunity comes from 
CD40L itself. Proper B cell activation and respective humoral immunity is 
dependent on T cell mediated help. The actual concept relies on MHCII 
presentation of antigens by B cells that are detected by CD4+ T cells, leading to 
T cell activation and CD40L upregulation. Interaction of CD40L with CD40 on the 
B cell provides the necessary “help” signal to induce B cell maturation, class 
switching and somatic hypermutation, which can be further supported by T cell 
secreted cytokines (IL-4, IFN-). Helper-type Tc2, Tc17 and Tc22 CD8+ T cells 
express CD40L with an intensity comparable to CD4+ T cells. CD40Lhigh IL-2 co-
secreting clones were shown to be superior to CD40Lint clones (IFN- co-
producers) in B cell activation and induction of Ig secretion (Hermann et al., 
1995). Furthermore, in HIV patients with reduced CD4+ T cell levels, the majority 
of CD8+ T cells exhibit an IL-4 secreting Tc2 phenotype and is capable of 
providing B cell help (Maggi et al., 1994, 1997). The increased frequency of 
CD40L+ CD8+ T cells when CD4+ T cell-mediated help is limited such as in 
ThPOK-/- and MHCII-/- mice models and CD4+ depletion experiments supports the 
ability of helper-type CD8+ T cells to provide MHCI dependent B cell help. As 
humoral immunity is ineffective against intracellular infections that are classically 
presented on MHCI, this CD8+ T cell mediated help might rather play a role in the 
response to cross-presented antigens. 
Help was furthermore shown to be an important aspect of cell mediated 
immune responses (Bennett et al., 1998; Janssen et al., 2003; Schoenberger et 
al., 1998; Shedlock and Shen, 2003). CD4+ T cells activate and license DC by 
CD40L-CD40 interaction, which leads to MHC upregulation and enables the DC 
to provide sufficient secondary (co-stimulatory receptors) and tertiary (cytokines) 
signals for optimal CD8+ T cell activation and induction of an effector response. 
Huber and Lohoff showed that a reverse variant of mediating help also exists. 
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Non-cytotoxic, IL-17 producing CD8+ T cells were necessary for the accumulation 
of strongly pathogenic CD4+ T cells in the CNS of murine EAE model (Huber and 
Lohoff, 2015; Huber et al., 2009, 2013). Accordingly, IL-17 producing CD8+ T 
cells were identified in active lesions of MS patients (Tzartos et al., 2008). 
Therefore, CD40L+ CD8+ T cells might not only contribute to efficient effector 
responses of CD8+ T cells but also the recruitment and activation of antigen 
specific CD4+ T cells. 
 
b) Cytokine secretion:  
Helper-type CD8+ T cells secrete a specific repertoire of cytokines (IL-4, IL-13, 
IL-17, IL-22, IL-10) that differ from classical CD8+ T cell mediated IFN- secretion 
(Figure 26). The functions of these cytokines were mostly identified by analysis 
of CD4+ T cells. However, the effect of the cytokines on their target cell is 
independent of their origin and therefore should also be induced by CD8+ T cell 
derived cytokines. IL-4, IL-5 and IL-13 secretion by Th2 cells is critical for the 
recruitment of eosinophils, which mediate the expulsion of parasites (Sallusto, 
2016). CD4+ T cell derived IL-4 and IL-5 moreover support B cell maturation and 
class switch in the presence CD40L-CD40 interaction. Th17 derived IL-17 in turn 
supports the clearance of extracellular bacteria and fungi by the mobilization of 
neutrophils (McDermott and Klein, 2018). And IL-22 produced by Th22 cells is 
assumed to play a role in skin regeneration as well as skin protection by inducing 
the production of antimicrobial peptides (Duhen et al., 2009; Sigmundsdottir et 
al., 2007). As helper-type CD8+ T cells are also capable to express CD40L in 
combination with IL-4 and IL-5, they can mediate according B cell class switching 
in a MHCI dependent manner (Hermann et al., 1995). IL-13, a feature of not only 
Th2 cells but also of all helper-type memory CD8+ T cells Tc2, Tc17 and Tc22 
has a protective function in skin regulating basal cell activity and subsequently it 
contributes to wound healing (Dalessandri et al., 2016). The different cytokines 
also can induce the release of chemokines by other cells, which modulate the 
recruitment of further cells. Accordingly, helper-type CD8+ T cells are capable of 
inducing CCL26 in keratinocytes, which in turn mediate the recruitment of CCR4+ 
cells whereas cytotoxic CD8+ T cells were demonstrated to recruit further CXCR3+ 
cells by the induction of CXCL11, instead (Figure 41).  
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There are multiple conditions where Tc2, Tc17 and Tc22 cells were 
detected. Tumors at barrier sites such as skin or lung (melanoma, lung cancer) 
often contain Tc2 cells (Minkis et al., 2008; Roberts et al., 2009; Sheu et al., 
2001). IL-13 producing Tc2 (most likely together with Tc17, Tc22) cells 
furthermore are widely associated with several autoimmune diseases in tissues. 
They are enriched in patients with systemic sclerosis (Cascio et al., 2017), 
alopecia areata (Czarnowicki et al., 2018), rheumatoid arthritis (Cho et al., 2012) 
and best described in asthma. Despite the vast majority of lung CD8+ T cells 
exhibit a cytotoxic memory (CXCR3+CCR5+) phenotype in patients with mild 
asthma only the small fraction expressing CCR4+ and producing IL-13 has been 
associated with disease progress (Campbell et al., 2001). Adoptive transfer of 
Tc2 cells that favored low antigen concentrations during priming but not Tc1 
primed OT-1 cells led to lung eosinophila and bronchial hyperresponsiveness, 
classical characteristics of asthma (Sawicka et al., 2004). Additionally, increased 
frequencies of IL-13 producing CD8+ T cells were found among bronchoaveolar 
lavage cells of asthmatic patients compared to healthy (Dakhama et al., 2013) 
and IFN- knockout led to a Tc2/Tc17 biased phenotype of lung CD8+ T cells with 
reduced cytotoxicity, paralleled by an aggravated disease (Tang et al., 2012). 
Hondowicz and his team showed that in mice sensitized with house dust CD4+ 
TRM in lung arise together with circulatory TCM in secondary lymphoid organs, a 
mechanism we propose to underlie the appearance of helper-type CD8+ T cell in 
the circulation (Hondowicz et al., 2016). A severe form of asthma is associated 
with high levels of Ig-E, which can mediate eosinophil and neutrophil activation. 
Secretion of Ig-E requires CD40L dependent activation of B cells in the presence 
of IL-4 and Tc2 cells could provide both as potential contributor to the worsening 
of asthma.  
But how are these helper-type cells activated in autoimmune diseases? IL-
17 and IL-22 producing CD8+ T cells in the epidermis were identified as major 
driver of psoriasis induction (Di Meglio et al., 2016). Triggers such as tissue 
traumata can result into a complex formation of keratinocyte derived antimicrobial 
peptide LL37 with self-DNA/RNA, which activates dendritic cells in skin to secrete 
IL-23. Those DC activate autoreactive CD8+ T cells which in turn release IL-17 
and contribute to skin lesions – a process also known as Koebner phenomenon 
(Lande et al., 2014). Similarly, Mrp8 and Mrp14 can induce autoimmunity. They 
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belong to the group of DAMPS (damage-associated molecular pattern molecules) 
that are constitutively expressed endogenous proteins and released upon tissue 
damage. The Mrp8 and Mrp14 protein load is increased in several autoimmune 
disorders such as multiple sclerosis, rheumatoid arthritis and psoriasis. When 
presented on DC paralleled by CD40-CD40L interaction with CD8+ T cells Mrp8 
and Mrp14 might mediate TLR4 ligation and IL-17 induction in the CD8+ T cells 
(Loser et al., 2010). Therefore, atypical structures that become accessible by cell 
disruption and/or complex formation possibly mimic high affine peptides for 
CD40L+ CD8+ T cells and activate them in a peptide independent mechanims. 
While CD40L expressing CD8+ T cells might usually contribute to tissue 
maintenance and/or tolerance of commensal bacteria, their CD40L expression is 
a disadvantage when untypical structures become accessible for example by 
tissue disruption. 
4.8  Conclusions 
In summary, this work demonstrated that the naïve CD8+ T cell repertoire is not 
homogeneous but compose of cells expressing CD40L implemented during 
positive selection in the thymus by recognizing self-peptide:MHCI complexes with 
high avidity (Figure 42). These cells possess a special TCR repertoire, inherit 
different priming abilities and differentiate into unique memory CD8+ T cell 
subsets with a Tc2, Tc17 or Tc22 phenotype and non-cytotoxic properties. We 
could demonstrate that these non-cytotoxic, helper CD8+ T cells resemble helper 
CD4+ T cells in their transcriptome and phenotype. Consequently, the features 
“cytotoxicity” versus “helper-phenotype” are not CD8+ versus CD4+ T cell specific 
but valid for the whole T cell compartment instead, distinguishable by the 
expression of SLAMF7 and IL-6R. 
Therefore, this work is not only challenging the unbiased flexibility of naïve 
CD8+ T cells but also the classical division of labor between MHC-II dependent, 
B-cell helping CD4+ T cells and cytotoxic CD8+ T cells killing infected/malignant 
cells in an MHC-I restricted manner. The CD4+ T cell compartment has already 
vastly diversified into different helper subsets, cytotoxic CD4+, TFH, TRM and Treg 
cells in recent years while actual reports indicate a similar plasticity of the CD8+ 
T compartment. We could demonstrate here that thymic imprinted, non-cytotoxic 
CD40L+ CD8+ T cells provides a unique CD8+ T cell type that has to be considered 
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when analyzing the contribution of CD8+ T cells to allergy, autoimmunity, 
inflammation and antitumorigenic responses.  
 
Figure 42: Concept of the role and fate of CD40L expressing CD8+ T cells in the 
immune system. During positive selection by cTECs in the thymic cortex a fraction of CD8+ 
T cells detects thymus proteasome processed private peptides with high affinity leading to 
the implementation of CD40L and high CD5 and NUR77 expression. These cells form a 
circulatory naïve T cell population with a unique TCR pool. Upon activation, they specifically 
differentiate into memory cells with skin migratory phenotype as well as type 2, 17 or 22 
cytokine secretion profiles. In contrast, CD40L- naïve cells can become CD40L+IFN-+ upon 
differentiation in the presence of IL-12 and gain either a type 1 or a type 17+1 memory 
phenotype with cytotoxic properties. These cytotoxic and non-cytotoxic memory CD8+ T cells 
are distinguishable by their opposite expression of SLAMF7 and IL-6R. While the cytotoxic 
cells contribute to control and elimination of intracellular infections, non-cytotoxic Tc2, Tc17 
and Tc22 memory cells might play an important role in skin barrier maintainance or 
commensal bacteria tolerance. 
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